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1.1
Outline
In 1912 Laue [1] was the first to suggest the use of a crystal to act as a lattice for
the diffraction of X-rays. He showed that if a beam of X-rays passed through a crystal,
diffraction would take place and a pattern would be formed on a photographic plate placed
at a right angle to the direction of the rays. The pattern would define the symmetrical
arrangements of the atoms in the crystal. Nowadays, X-ray crystallography has become a
general tool for the determination of the three-dimensional structure of proteins.
In this thesis, X-ray crystallography was used to determine the three-dimensional
structure of several proteins. Chapter 1 is an introduction to two of the proteins
investigated in this thesis (human T cell receptor - CD3 complex and bacteriophage T4).
The impact of single amino acid substitutions in CD3γ on the CD3εγ interaction
and T cell receptor - CD3 complex formation is described in chapter 2.1. The results
indicate that several amino acids in CD3γ are essential for an optimal association between
CD3γ and CD3ε and the assembly of a cell surface expressed TCR-δεγεζ2 complex. In
order to determine the three-dimensional structure of the intracellular domains of CD3δ
and CD3ε, synthetic peptides corresponding to these domains were synthesised and used
for crystallisation experiments and analysed by NMR. The results are described in
chapter 2.2.
The crystal structure of the receptor-binding domain of the bacteriophage T4 short
tail fibre is described in detail in chapter 3.1. The trimeric protein has a novel knitted
trimeric metal-binding fold and contains the receptor-binding domain. This receptor-
binding domain recognises and binds irreversibly to the core region of the host cell LPS.
We propose where the LPS-binding region is located. In chapter 3.2, preliminary results
are described obtained from a new crystal form of the short tail fibre. In these crystals the
electron density for the short tail fibre is more ordered compared to the structure
determined in chapter 3.1.
Chapter 4 describes the crystallographic studies of a dimeric double-headed potato
serine protease inhibitor of the Kunitz family. These are the first crystallisation conditions
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described for a dimeric double-headed inhibitor. To date, only monomeric single-headed
or monomeric double-headed inhibitors have been crystallised.
The protein structure of recombinant human lactoferrin produced in the milk of
transgenic cows is identical to that of natural human lactoferrin, despite a differential N-
linked glycosylation. These results confirm the validity of transgenic cows to produce
recombinant human proteins and are described in chapter 5.
This thesis is finalised with a summary and conclusions, which are described in
chapter 6.
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1.2
Human T cell receptor - CD3 complex
The T cell receptor (TCR) is present on T cells, which are a subset of lymphocytes
defined by their development in the thymus and by the expression of the T cell receptor.
The function of the T cell receptor is to sense the presence of intracellular pathogens
which is a crucial step towards the initiation of a specific immune response aimed at the
eradication of such pathogens. TCRs are heterodimeric receptors that are cell surface
expressed in association with the proteins of the CD3 complex [2]. There are various
subsets of T cells. The two major subsets are the CD8+ and CD4+ T cells. The cytotoxic
CD8 cells can kill infected target cells thereby preventing replication of intracellular
pathogens. The helper CD4 cells are crucial for the initiation and regulation of immune
responses as well as providing help for B cells which results in antibody production. After
the T cells have developed in the thymus they go into the bloodstream, from where they
migrate through the peripheral lymphoid organs e.g. the lymph nodes, spleen, and
mucosal-associated lymphoid tissue where immune responses are induced. Subsequently,
they re-enter into the blood stream, where they circulate until they encounter antigens [3].
The immune system
The human immune system has evolved to protect us from invading pathogens.
The immune system can roughly be divided in two parts: the innate or natural immune
system and the adaptive or specific immune system. The innate immune system is
inherited by birth and is non-specific. Important components of the innate immune system
are neutrophils and the complement system. Neutrophils are short-lived leucocytes that
penetrate inflamed tissues and destroy pathogens upon phagocytosis. The complement
system tags invading pathogens, facilitating receptor-mediated uptake by phagocytes, and
also works through soluble factors produced by the adaptive immune system, the
immunoglobulins. The adaptive immune system response develops and is continuously
reshaped during the lifetime of an individual. The main components of the adaptive
immune system are the B and T cells, lymphocytes with clonotypic cell-surface receptors
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for the recognition of the foreign antigens. While the B lymphocytes produce antibodies
for antigen removal from the circulation, the T lymphocytes track down and eliminate
infected cells. These lymphocytes provide the life-long immunity that develops after
exposure to a disease or vaccination [2].
T and B lymphocytes development
The central or primary lymphoid organs are the bone marrow and the thymus. Both
B and T cells originate in the bone marrow but only the B cells mature here. The T cells
migrate to the thymus for maturation. After maturation both lymphocytes enter the blood
stream. From here they migrate into the peripheral lymphoid organs. These peripheral
lymphoid organs are specialised to trap antigen and allow the initiation of adaptive
immune responses.
The T cell precursors entering the thymus express neither the T cell receptor nor
one of the two co-receptor molecules CD4 or CD8, and are called double-negative cells.
During proliferation these immature thymocytes differentiate into double-positive cells,
with low T cell receptor levels and both co-receptor molecules. The T cells developing in
the thymus randomly rearrange their T cell receptor encoding genes creating a vast array
of TCRs. However, since it is random, it generates T cells that are potentially harmful for
host tissues when their TCRs recognise combinations of MHC and self-peptides.
Rearrangement can also produce cells that are useless because their TCRs interact too
poorly with MHC molecules. To allow the survival of only the useful T cells, a two step
process called positive and negative selection is performed. During positive selection
TCRs are selected that have an affinity for MHC-peptide complexes expressed in the
thymus. Subsequently, through negative selection those thymocytes expressing a TCR
with a too high affinity for MHC-peptide are eliminated through the induction of
apoptosis. The result is a TCR repertoire with an intermediate affinity for self MHC-self
peptide which can react with self MHC-foreign peptide in the periphery. Next to
rearrangement and selection, the cells differentiate in one of the two lineages, the CD4 or
CD8 single-positive cells. As each T cell expresses a distinct TCR, a vast array of
receptors is available for recognition of foreign peptides bound to self MHC. Because of
this antigen-binding specificity, the fraction of T cells that can respond to a particular
antigen is very small. After an infection many specific effector lymphocytes are required,
and hence the activated lymphocytes are induced to proliferate before they differentiate
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into effector cells. This major feature of the adaptive immune response is called clonal
expansion [2].
The development of B cells follows a specific order of stages [2,4]. The earliest B
cell precursor is the early pro-B cell, which has no B cell antigen receptor expression on
the cell surface. These cells further develop into late pro-B cells, pre-B cells, immature B
cells and mature B cells. In these stages the immunoglobulin gene recombination occurs.
Many thousands of rearrangements are possible for both heavy- and light-chain genes.
Thus, rearrangement during the B cell development is continuously providing immature B
cells with a highly diversified repertoire of surface immunoglobulin molecules, all acting
as specific receptors for different antigens. All the processes up to the development of the
immature B cells take place in the bone marrow and are independent of antigen. Immature
B cells only express surface IgM and (like T cells) they undergo a selection. The
immature B cells are subjected to selection for self-tolerance. The B cells that recognise
self-molecules while still immature are prevented from further development. The B cells
that survive this selection bear a B cell receptor (BCR) repertoire tolerant of the self-
molecules and become mature. They are called "naive" until they encounter their specific
antigen. During this maturation the cells migrate into the secondary lymphoid organs and
the cells are induced to express IgD on their cell surface (next to IgM) through alternative
splicing of heavy-chain transcripts [2].
B cell mediated immunity or humoral immune response
B cells prevent the spread of intracellular infections by secreting antibodies. The
activation of naive B cells and their differentiation into antibody-secreting cells is
triggered by antigen and helper T cells. The B cells first internalise the antigen and then
process and degrade it. The peptides resulting from these antigen proteins are presented to
the T cells via MHC class II molecules. The helper T cells recognise the peptides derived
from the antigen and act through the binding of its CD40L (CD40 ligand) to CD40 on the
B cell and by the directed release of cytokines. This results in an activated B cell which
produces antibodies against the specific antigen. There are several ways in which these
antibodies contribute to immunity. Antibodies can bind to a bacterial antigen, which can
prevent the growth, and diminish bacterial adherence. This reduces spread from cell to
cell, thus neutralising the bacterial invasion. Binding of the antibody to an antigen in order
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to enhance phagocytosis (the internalisation of particular matter by cells e.g.
macrophages) is called opsonisation. Thirdly, when antibodies bind to the surface of the
pathogen, this can activate the complement system, enhancing opsonisation [2,3].
T cell mediated immunity
T cells identify cells that harbour pathogens or have internalised pathogens or their
products. They do so with their T cell receptor-CD3 complex. The peptide fragments of
pathogen derived proteins are recognised in the form of complexes of peptide and Major
Histocompatibility Complex (MHC) molecules on the cell surface of the antigen
presenting cell (APC). There are two types of MHC molecule, called MHC class I and
MHC class II, which are closely related in structure and function, but they have a different
subunit structure. Also, they differ in the source of the peptides they bind and express on
the cell surface. The folding motif of the two types of MHC-classes has been revealed by
X-ray crystallography and they were found to be very similar [5-8].
MHC class I
MHC class I molecules entrap peptides derived from proteins synthesised in the
cytosol. MHC class I has a transmembrane heavy chain (Hc or α-chain, 45 kDa) which is
non-covalently associated with the β2 microglobulin (β2M, 12kDa). The α-chain consists
of three immunoglobulin-like domains, the peptide binding groove is formed by the two
membrane distal domains which form two α-helical segments on top of a series of β-
sheets. The resulting groove can accommodate peptides that are usually 8-10 amino acids
in length. Binding of the peptides is mediated by interactions between side chains of
amino acids in the peptide (anchor residues) with pockets in the MHC molecule.
Moreover, binding is stabilised at the free carboxy and amino end by hydrogen bonds.
MHC class I captured peptides are recognised by cytotoxic T cells (CD8), which kill the
infected cell.
MHC class II
MHC class II molecules bind peptides derived from proteins in intracellular
membrane-bound vesicles or internalised antigen in B cells or phagocytic cells. MHC
class II molecules consist of a 32 kDa α-chain and 29 kDa β-chain which both cross the
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membrane. The peptide binding groove is very similar to that of class I molecules but is
open at both ends. As a result, the length of the peptides bound to the class II MHC
complex is not as constrained as that of class I peptides. Peptides that can bind are at least
9 amino acid residues long, but most are longer. The peptide lies in an extended
conformation along the MHC class II peptide-binding groove which allows multiple
interactions that contribute to binding. Moreover, the peptide's side-chains protrude into
shallow and deep pockets present in the groove of the MHC class II molecules.
MHC class II molecules captured peptides are recognised by TH1 or TH2 type,
CD4+ T helper cells. TH1 cells activate macrophages leading to destruction of the
intracellular bacteria, whereas TH2 activates B cells which subsequently proliferate and
differentiate into an antibody-producing plasma cell [2,3].
The T cells recognise the peptide-MHC complex via their T cell receptor CD3
complex, of which the chains have a Fab-like structure that is similar to the B cell
receptor. Contrary to the BCR, which gets excreted after antigen stimulation, the TCR
stays membrane associated for recognition of peptide-MHC complexes on antigen-
presenting cells.
The αβ TCR-CD3 complex
There are two types of T cell receptor, the αβ TCR and the γδ TCR. Here we focus
on the αβ TCR. The αβ TCR interacts with peptide antigens bound to MHC. The TCR
(Figure 1.1) consists of a disulphide-linked hetero-dimer (αβ) that is expressed on the cell
surface in association with the CD3 complex [9].
The glycosylated TCRαβ, which has a Fab-like structure, is responsible for the
recognition of a specific antigen bound to MHC-molecules. The associated CD3 complex
consists of one CD3γ-chain, one CD3δ-chain, two CD3ε-chains, and a ζ-dimer
(αβγεδεζ2). Subsequently, the CD3 components, which are in close proximity and all
have immunoreceptor tyrosine-based activation motifs (ITAM) in their intracellular
domain, through a still not completely understood process transduce and activate the
intracellular signalling pathways [10-13]. The CD3δ, ε, and γ all have a large extracellular
immunoglobulin (Ig)-like domain, a membrane proximal stalk region, a transmembrane
helix, and the intracellular ITAM containing domain. This in contrast to ζ, which has a
small extracellular domain and a large intracellular domain with three ITAMs. The CD3
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components are not only required for transduction of the signal across the cell membrane,
but also for the expression of the TCR heterodimers on the T cells. If one of the CD3
chains is absent, e.g. due to a genetic mutation, the number of T cell receptors present on
the cell surface is reduced [14-16].
Stoichiometry and assembly of TCR-CD3 complex
Several crystal structures have been elucidated for parts of the αβTCR-CD3
complex [17-20]. Garcia et al. [21] determined the structure of the complete extracellular
fragment of a glycosylated αβTCR at 2.5 Å resolution and its orientation bound to a class
I MHC-peptide complex. Garboczi et al. determined the structure of the complex between
the human T cell receptor, viral peptide, and HLA-A2 [22]. Sun et al. [23] discovered the
structure of an ectodomain fragment of the murine CD3εγ heterodimer. Recently Kjer-
Nielsen et al. elucidated the crystal-structure of the human T cell receptor CD3εγ
heterodimer complexed to the therapeutic mAb OKT3 [24]. They show that the binding
interface between CD3ε and CD3γ is mainly formed by hydrogen bonds, salt-bridges and
hydrophobic interactions. A side-to-side hydrophobic interface between the two Ig-like
domains and parallel pairing of their respective C-terminal β-strands were revealed
(Figure 1.2).
Figure 1.1. The T cell receptor is made
up of antigen-recognition proteins and
invariant signalling proteins. Picture
adapted from [2].
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Due to better techniques in crystallography and nuclear magnetic resonance
(NMR), more and more structures of the TCR-CD3 complex are being determined [25-
31], but the precise stoichiometry of the TCR-CD3 complex still is the subject of major
discussions in the field. In particular, there are still discussions going on whether α-chain
and β-chain are present as one or multiple heterodimeric pairs. Punt et al. [32] and de la
Hera [33] found that each TCR-CD3 complex contains one αTCR, one βTCR and two
CD3ε chains. This in contrast to San José [34], Fernández-Miquel [35], and Exley [36]
who all found evidence for a double TCR heterodimer model e.g. αβγεεδζζαβ. There is
even evidence for yet another stoichiometry given by Thibault and Bardos [37] who
suggest the association of two TCR heterodimers with three CD3ε chains in the TCR-CD3
complex. In one of the latest developments in determining the stoichiometry Call et al.
[38]  suggest that the αβTCR-CD3 complex assembled in the endoplasmic reticulum (ER)
is monovalent and composed of one copy of the αβTCR, CD3δε, CD3γε and ζζ-dimers.
The assembly of the TCR-CD3 complex follows discrete steps, in which the
transmembrane (TM)-region of CD3δε, CD3γε and ζζ-dimers play an important role. The
TM domains of the receptor components have a total of nine basic/acidic residues [39]
Figure 1.2. Structure of the OKT3 Fab/CD3 complex.
Ribbon representation showing the heavy and light chain
of OKT3 Fab fragment complexed to CD3. The CD3ε
monomer contains eight β-strands, whereas the CD3γ
subunit contains seven β-strands. Picture adapted from
[24].
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(Figure 1.3). Three basic residues are located in the TCR TM-region, whereas each of the
three signalling dimers has a pair of acidic residues in their transmembrane domain.
If TCR complexes are multivalent the apparent charge imbalance problem in the
TCR-CD3 complex could be overcome. If two TCR heterodimers would be present in the
complex, the number of basic residues is exactly the same as the number of acidic
residues in the TM region of the CD3 chains. Several different groups examined the
assembly of the TCR-CD3 complex. Brenner and colleagues [40] demonstrated the
interaction between βTCR and CD3γ by using crosslinking techniques and Geisler et al.
showed that the αβTCR-CD3δε intermediate was formed in jurkat cell line deficient in
expression of the CD3γ chain [41]. Call and Wucherpfennig [39,42] proposed a molecular
mechanism for the assembly of the TCR-CD3 complex. A schematic overview of the
proposed assembly mechanism is shown in Figure 1.4. They showed that each basic TCR
residue in the helical TM spanning domain is required for assembly with a particular
signalling dimer, thereby forming a three-helix. The two lysine residues (K) are located in
the middle of the TM region of αβTCR and serve as critical contact points for assembly
with CD3δε and CD3εγ dimers, respectively. The ζζ-dimer associates with the arginine
(R) residue present in the αTCR.
There is proof that the association of CD3εγ with the TCR is more efficient in the
presence of CD3δε, which indicates that the kinetically preferred order in assembly of
αβTCR is with CD3δε (1) followed by CD3εγ (2) and the final association is the ζζ-dimer
(3). However, in this proposed assembly mechanism there is a charge imbalance in the
transmembrane region as it would lead to six acidic residues and only three basic ones, as
written above. Call et al. [39] give a possible explanation why this may not be a problem.
Figure 1.3. Components of the TCR-
CD3. Picture from [39]. Basic amino
acids are arginine (R) and lysine (K) and
acidic amino acids are glutamic acid (E)
and aspartic acid (D).
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They propose that each assembly event leads to the creation of a three-helix interface at
which the basic and two acidic residues are shielded from the surrounding lipid. Partial or
complete protonation of the acidic residues reduce the average net charge for the aspartic
acid pair, and hence this rearrangement does not necessarily lead to a charge imbalance.
T cell receptor signalling
As the αβTCR chains have very short intracellular domains, they lack domains
which could be responsible for signalling. Instead the transmembrane CD3 domains,
which are in close proximity to the TCR chains, transduce the signal from the
extracellular environment into the cell [13]. The CD3δ, ε, γ, and ζ-chain all have the
intracellular sequence YXXI/L(4-6X)YXXI/L, termed the immuno tyrosine-based
activation motif (ITAM). These ITAMs play a vital role in signalling from the CD3
complex further into the cell [43,44]. Several different models have been proposed during
the last years, all describing different models of intracellular signalling events in T cells.
Boniface et al. [45] describe that the initiation of signal transduction through the T cell
receptor requires the multivalent engagement of peptide/MHC ligands for effective
activation. In 2003, Alarcón et al. [46] proposed that changes in the interaction between
CD3 subunits within the CD3 dimers and the interaction of these dimers with the TCR
heterodimer could be the triggering mechanism that initiates the first activation events.
Upon TCR triggering activation of various receptor-associated protein tyrosine
kinases (PTKs) of the Src family takes place, such as Fyn or Lck, upon recruitment of the
Figure 1.4. Organisation of the TCR-CD3 assembly. The important amino acid residues in
each chain are given in one-letter code. D = aspartic acid, E = glutamic acid, K = lysine, and R
= arginine. The assembly steps are numbered according to the order in which they occur.
Figure adapted from [39].
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CD4 or CD8 co-receptor to the TCR-CD3 complex. By recruitment of the co-receptor to
the TCR MHC-ligand complex, Lck or Fyn is brought into close proximity of the TCR-
CD3 complex. Lck and Fyn have kinase activity and are associated with the cytoplasmic
domain of the co-receptor CD4 and CD8. This recruitment results in phosphorylation of
the CD3 ITAMs [13]. After phosphorylation of the CD3-ITAMs, ZAP-70 (an ζ-associated
protein having an SH2 domain) binds to the phosphorylated ITAM of CD3ζ. Then Lck or
Fyn activates ZAP70 by phosphorylation. After activation, ZAP70 phosphorylates
components of several downstream signalling pathways [2,47].
A recent review by Abraham and Weiss [48] depicts our current understanding of
T cell receptor signalling that has evolved over the last years. Although thorough research
has led to a better understanding of T cell signalling, structural information on the
components of the signalling cascade is still largely missing. With protein production,
crystallographic and NMR techniques on their current levels of sophistication, this
problem may be overcome in the near future.
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1.3
Bacteriophage T4
The word "phage" comes from the Greek phagein, meaning "to eat" and the word
"bakterion" meaning "small staff" in Greek. A bacteriophage is a virus that infects
bacteria. Bacteriophage T4 infects Escherichia coli (E. coli), an organism well known to
most molecular biologists. It is one of the most complex viruses with a genome that
contains 274 open reading frames out of which more than 40 encode structural proteins
[49]. The phages multiply inside the bacteria by using the host's biosynthetic machinery;
phages always need a host cell, as they are not capable of living without one. T4
bacteriophage is a very efficient DNA injection machine; generally a single T4 phage
particle is enough to infect a host cell [50]. The virus consists of a double stranded DNA-
containing head, a double-tubed tail of which the outer tail-sheath is contractile, and a
baseplate to which six long tail fibres and six short tail fibres are attached (Figure 1.5).
With these tail fibres the phage attaches to its host cell, after which it penetrates the cell
membrane and subsequently releases its DNA into the host. Like several other phages, T4
DNA contains a modified base, which protects the DNA from the restriction system of the
infected host cell.
Lately, more structural details of the bacteriophage T4 became available, due to better
techniques in electron microscopy and X-ray crystallography.
Figure 1.5. Schematic structure
of bacteriophage T4. Picture from
http://www.nsf.gov/od/lpa/news/
02/pr0207.htm.
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Bacteriophage T4 features
Bacteriophage T4 has a plating efficiency that approaches one, meaning that
virtually every phage particle plated on a lawn of susceptible bacteria is capable of
forming a plaque. As well as very efficient, the absorption of the phage to the host cell is
very rapid. Bacteriophage T4 uses several different mechanisms to arrest the synthesis of
nucleic acids and proteins of the infected host cell. Another feature is the burst size: 100-
500 phage particles are produced per infected cell within 15 to 30 minutes at 37 °C [51].
The T4 life cycle
Bacteriophage T4 replicates by the so-called lytic cycle [51]. A cycle is called
lytic, when new viruses are produced within the infected bacterium and the viruses lyse
the infected host bacterium in order to be released. The replication cycle exists of several
stages, starting with adsorption; the bacteriophage attaches to the receptors in the
bacterial cell wall of the host cell. Next comes the penetration; the phages make holes in
the host cell, through which they can inject their genome. Most of the phages do this by
contraction of the outer tail sheath, which drives the hollow inner tail tube into the host
cell. Penetration is followed by replication, in which T4 proteins partially shut down the
macromolecular machinery of the host cell and direct the replication of the bacteriophage
genome and structural components. For this replication, T4 uses the metabolic machinery
of the host cell to synthesise phage enzymes and structural components. Maturation
consists of the phage parts assembling around the genomes. Finally, during the reinfection
step, T4 lysozyme lyses the bacterial peptidoglycan layer causing osmotic lysis,
implicating the release of new T4 bacteriophages [52].
Bacteriophage T4 DNA
The bacteriophage contains 172 kb of linear double stranded DNA, made up of 5-
hydroxymethyl dCMP (Hm-dCMP) building blocks instead of cytosine, as well as the
normal dAMP, dGMP and dTMP nucleotides. Apart from this modification, T4 also
modifies the Hm-dCMP residues by glycosylating them, after the precursor has been
incorporated. Glucose is covalently bound to the T4 Hm-dCMP residues in 70 % of the
cases in the α-configuration and the remaining 30 % in the β-configuration (Figure 1.6).
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These modifications provide the T4 DNA with an efficient protection system against the
host restriction mechanism [51].
Molecular chaperones in T4 assembly
The assembly of the bacteriophage occurs in different, separated stages all under
the control of a number of bacteriophage encoded gene products, also called chaperones
[53]. The co-chaperone gp31 in a complex with the host chaperone GroEL, facilitates the
folding of the T4 major capsid protein gp23, of which 960 copies are necessary during
morphogenesis [54,55]. Mutations in either gp31 or GRoEL genes cause the formation of
amorphous aggregates in the cell, which are similar to inclusion bodies [56]. GRoEL
consists of monomers of approximately 60 kDa and is found in bacteria, chloroplasts, and
mitochondria [57]. Native GRoEL is composed of 14 identical subunits, each containing
548 amino acids, in two rings of seven monomers each. The overall shape is a "double
donut" with a 125-130 Å diameter and a height of 100-155 Å, with a central 30 Å-hole
[58-60]. GRoEL binds to several unfolded polypeptides in vitro, preventing their
premature aggregation and thus promoting their correct folding and oligomerisation [57].
Gp31 is a 12 kDa protein, which is similar to GRoES in size and isoelectric point
[61], but without significant homology between the amino acid sequences. Like GroES, it
is a heptamer and forms a stable complex via its mobile loop with GRoEL in the presence
of Mg-ATP [55,62,63]. Keppel and co-workers [62] demonstrated that when gp31 is
expressed in E. coli, the otherwise essential GRoES can be deleted.
Gp57A is also a chaperone in the T4 assemblage; the short tail fibre (STF) protein
gp12 and the long tail fibre (LTF) proteins gp34 and gp37 need this chaperone for
correctly folding. The exact mechanism remains unclear. Gp57A contains 79 amino acids,
Figure 1.6. Structures of glucosylated Hm-dCMP residues in T4 DNA a) α-D-glucosyl-5-hydroxy
methyl-deoxycytidine 5'-monophosphate b) β-D-glucosyl-5-hydroxymethyl-deoxycytidine 5'-
monophosphate.
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is assumed to be oligomeric and acidic (it has an excess of 9 negative charges) and its
composition is somewhat strange, as it does not contain any Phe, Trp, Tyr, His, Pro or Cys
[64,65].
Receptor recognition
The T4 bacteriophage recognises the host cell by its receptors: The long tail fibres
recognise the outer membrane protein C (OmpC) or lipo-polysaccharide (LPS) in E.coli B
and are responsible for the initial, reversible, attachment of the bacteriophage. After
change of conformation of the baseplate, the short tail fibres extend from the baseplate
and bind irreversibly to the core region of the host cell's LPS. Both LPS and OmpC are
present in the outer cell wall of all Gram negative bacteria. LPSs often called endotoxins,
are complex molecules with molecular weights of about 10 kDa and their compositions
can vary widely between different species. The general architecture of LPS is shown in
Figure 1.7 [66].
polysaccharide                                lipid
Region 1 is composed of Lipid A and is the hydrophobic, membrane-anchoring
region of LPS. This domain is responsible for the toxicity of LPS. Lipid A consists of a
phosphorylated N-acetylglucosamine (NAG) dimer with usually 6 saturated fatty acids
attached. The structure of region 1 is highly conserved among different species. Region 2
is called the core (R) antigen or R polysaccharide, it is attached to the 6 position of one
NAG and contains a short chain of sugars. Two unusual sugars are present most of the
time in the core polysaccharide; heptose and 2-keto-3-deoxyoctonic acid (KDO). Region 2
is very similar among species. Region 3, called somatic (O) antigen or O polysaccharide is
attached to the core polysaccharide, consisting of repeating oligosaccharide subunits.
Figure 1.7. General overview of lipopolysaccharide. The polysaccharide domain is responsible
for the immunogenicity of the LPS, whereas the lipid domain is responsible for the toxicity.
Picture adapted from [66].
O-specific chain outer core inner core lipid A
Region 3 Region 2 Region 1
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Region 2 and 3 together are responsible for the immunogenicity of the LPS. Region 3
contains the hydrophilic domain of the LPS molecule. There are major differences in this
region between different species and even between strains of Gram negative bacteria [66].
In B type E. coli, the distal end of the LPS has a glucose region, which is the important
residue for receptor function, whereas in the K-12 strain the corresponding glucose is
masked by additional glucose and galactose molecules [67,68].
OmpC, the alternative receptor for the bacteriophage T4, is a trimeric protein often
called porin. Its molecular weight is 40368 Da. OmpC forms pores or channels through
the outer membrane to allow passage of hydrophilic molecules. Porins allow nutrients to
pass through the membrane inwards, while excluding harmful hydrophobic compounds.
Bacteriophage T4 morphology
Assembly of the T4 bacteriophage can be divided into three independent stages:
head, tail and long tail fibre assembly. Some stages or assembly steps are dependent on
specific chaperones (see above). An overview of the assembly of bacteriophage T4, the
required stoichiometries and the necessary chaperones is given in Figure 1.8 [69].
Before the work described in this thesis, the structures of several gene products of
the bacteriophage T4 or chaperones necessary in the different assembly steps were already
elucidated by X-ray crystallography or NMR spectroscopy. In Table 1.1, the proteins of
known three-dimensional structure are given with their corresponding location in the
bacteriophage, and the resolution to which the structures were determined. As can be seen
in Table 1.1, Kostyuchenko and co-workers fitted the crystallographic data of many gene
products into a cryo-electron microscopy map of the base plate obtained to 12.0 Å
resolution [70].
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   Gene
product
location of gp PDB
code
Method resolution
(Å)
reference
gp11 base plate - STF
connector
1EL6 X-ray 2.00 [71]
1PDF EM 12.00 [70]
gp8 base plate 1N7Z X-ray 2.00 [72]
1N8O X-ray 2.45 [72]
1N8B X-ray 2.90 [72]
1PDM EM 12.00 [70]
gp12 short tail fibre 1H6W X-ray 1.90 [73]
1PDI EM 12.00 [70]
gp9 baseplate - LTF
connector
1QEX X-ray 2.30 [74]
1S2E X-ray 2.30 [74]
gp27 base plate - gp5
connector
1K28 X-ray 2.90 [75]
1PDJ EM 12.00 [70]
gp5 cell puncturing device
and tail associated
lysozyme
1K28 X-ray 2.90 [75]
1PDL EM 12.00 [70]
Wac whisker antigen control 1RFO NMR [76]
1OX3 X-ray 2.00 [77]
Table 1.1. Overview of the bacteriophage T4 gene products (gp) of which the structure has
been determined by X-ray crystallography and EM. Denoted are their corresponding location
in bacteriophage T4, PDB-code, method of structure determination, and the resolution to
which the structures are determined, respectively.
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The different constituents of the bacteriophage T4 are described below.
Figure 1.8. Morphogenesis of bacteriophage T4. The overall assembly can be divided into three
independent stages: head, tail, and long tail fibre assembly. The chaperones and catalytic proteins
are indicated in brackets near the protein, or assembly step, that requires the chaperone. Known
stoichiometries are given in the subscript. Crystal structures of structural proteins are shown as
ribbon diagrams. (Picture kindly supplied by P. Leiman [69]).
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The double stranded-DNA containing head
The T4 head structure was determined by cryo-electron microscopy [78,79]
(Figure 1.9). The head is composed of 160 hexamers of gp23* (According to phage
genetics usage, gpX* signifies the product of maturation by the cleavage of gpX to gpX*)
and 11 pentamers of gp24* together with hoc (highly antigenic outer capsid protein) and
soc (small outer capsid protein). Together they form a shell of about 30 Å thickness
encapsulating the double stranded DNA [78,80]. Whereas the soc protein helps to stabilise
the capsid against extremes in pH, hoc only has a marginal effect on head stability
[80,81]. Both proteins are not absolutely necessary for head morphogenesis and phage
infection. The mature T4 head is elongated along the five-fold axis (Figure 1.9). The
diameter was found to vary from around 973 Å along the five-fold axes to about 879 Å
along the three-fold and two-fold axes. The length of the mature T4 head is around 1150
Å. The surface of the prolate icosahedron is composed of two end-caps each made of five
equilateral triangular facets and connected by an elongated midsection, made of ten
triangular facets. The facets of the T4 head are composed of gp23* [78,79]. The eleven
vertices are occupied by pentamers of gp24*, whereas the 12th vertex is a special portal
for DNA packing, tail attachment, and DNA exit. The portal protein, gp20, assembles as a
dodecamer and is often called the "connector" [82,83].
Bacteriophage T4 tail
The tail of T4 consists of two concentric cylinders. The contractile outer sheath and
the tube consist of gp18 and gp19, respectively. The inner cylinder, called the tail tube, is
built of 144 copies of gp19 [84-86]. The outer diameter of the tail tube is 90 Å, with a 40
Å-diameter inner channel, through which the DNA passes from the T4 head to the host
cell [87]. The outer cylinder is called the tail sheath, has an outer width of about 210 Å
and is thought to be composed of 144 copies of gp18 [84]. However, Leiman et al. [88]
recently determined that only 138 copies of gp18 and gp19 are present in the T4 tail. The
top end of the tail tube contains gp3, which probably acts as a "paste" protein between the
tail sheath and tail tube. It stabilises the tail sheath and prepares the tail for the addition of
the terminal capping protein, gp15. Vianelli [50] and co-workers concluded that gp3 is an
integral part of the tail, localised at the tip of the tube and capable of preventing abnormal
extension of the tail tube during assembly.
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Figure 1.9. Structure of the bacteriophage T4 head. The facet triangles are shown in blue and
the basic triangles are shown in black. A) Shaded surface representation of the cryo-EM
reconstruction viewed perpendicular to the five-fold axis. Gp23* is shown in blue, gp24* is
in magenta, soc is in white, and hoc is in yellow and the tail is in green. B) Model of the
previously proposed T4 head structure. C) View of the reconstruction along the five-fold axis
at the portal vertex towards the observer; the tail has been cut away at the level of the black
arrow in A. Proteins are coloured as described in A. D, Left) Schematic representation of
distribution of proteins in the elongated midsection facet. D, Right) Schematic representation
of an end-cap facet. Proteins are coloured as in A, except for the soc molecules, which are
shown as grey rectangles. (Picture from [79]). For colour picture see Appendix A.
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Baseplate
The three-dimensional structure of the bacteriophage T4 baseplate was determined
to a resolution of 12 Å by cryo-electron microscopy [70]. The baseplate contains
approximately 150 sub-units of at least 16 different proteins ranging from 14 kDa to 140
kDa in size (Figure 1.10). It is a dome-like structure with down-facing pins at the vertex
and has a diameter of 520 Å [70]. The baseplate is built out of six identical wedges which
surround a central hub [89]. The wedges are built by the sequential assemblage of gp11,
gp10, gp7, gp8, gp6, gp53 and gp25 [70].
The central hub contains gp5 and gp27 [75] (Figure 1.11). Gp27 serves as an
interface (symmetry-adjuster) between the six wedges and the threefold-symmetry of the
hub [90]. Two β-barrel domains of gp27 in the trimer are related by quasi-sixfold and
exact three-fold symmetry [75]. Gp5 has several domains of which one is the so-called
"tail lysozyme" [91]. Gp5 is the only baseplate protein that undergoes processing by
proteolysis and the only one that has enzymatic activity. Its lysozyme domains digest the
intermembrane peptidoglycan layer of the host's cell wall during penetration.
Figure 1.10. Structure of the baseplate tail tube complex. a-c) The baseplate and proximal
part of the tail tube. Colours identify proteins labelled with their corresponding gene number.
Unidentified protein X at the tip of gp5. a) Side view. b) End-on view. c) Cross-section.
Picture adapted from [70]. For colour picture see Appendix A.
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The C-terminal domain of gp5 acts as a membrane-puncturing needle and the N-terminal
domain of gp5 is inserted into a cylinder formed by three gp27 monomers, which may
serve as a channel for DNA ejection after cell wall penetration and dissociation of the
needle part of gp5 [75] (Figure 1.11).
Long and short tail fibres
Long and short tail fibres are connected to the baseplate via gp9 (long-tail fibre
connecting protein) and gp11 (short-tail fibre connecting protein), respectively. The long
tail fibres are composed of gp34, gp35, gp36 and gp37. These fibres are approximately
1450 Å long and up to 40 Å in diameter. They recognise the OmpC or LPS of E. coli by
their C-terminal domain and are responsible for the initial, reversible attachment of the
bacteriophage. After at least three long tail fibres have bound, the baseplate changes
conformation from the "hexagon" form to the "star" form [88,92] (Figure 1.12). In the
hexagon form the short tail fibres, trimers of gp12, are incorporated into the baseplate in
bent fashion, as can be seen in Figure 1.10 [75]. Upon conversion of the baseplate to the
star form, STFs extend from the base plate and bind irreversible with their C-terminal
domain to the core region of the host cell LPS [93]. Here they form inextensible stays,
Figure 1.11. Structure of the gp5-gp27 trimeric
complex, shown with its threefold axis in the
plane of the paper. Picture from [75].
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allowing penetration of the cell envelope by the base plate hub and tail tube upon
contraction of the outer tail-sheath [75].
The DNA injection machinery
After the C-terminal domain of the STFs have irreversibly bound to the core region
of the host cell LPS [93], the tail sheath contracts, driving the rigid tail tube through the
outer cell membrane, using the needle that is located at the end of the tube. The
puncturing needle is formed by the gp5 C-terminal β-helix. When the β-helix comes into
contact with the periplasmic peptidoglycan layer, it is thought to dissociate, activating the
three lysozyme domains of gp5 (Figure 1.11). These lysozyme domains digest the
peptidoglycan layer, enabling the tail tube to reach the cytoplasmic membrane of the host
cell. Finally, the viral DNA is injected into the host cell cytoplasm, after which the
replication, maturation and re-infection can take place.
Figure 1.12. Image analysis of a) normal/hexagonal-form and b) contracted/star-form of T4
baseplate. Different colours identify different proteins as in figure 1.10; gp7 (red), gp8 (blue), gp9
(green), gp10 (yellow), gp11 (cyan), and gp12 (magenta). Directions of the long tail fibers are
indicated with gray rods. Picture adapted from [88]. For colour picture see Appendix A.
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1.4
Scope and aim of this thesis
The initial aim of my thesis research was to determine the 3D structure of the
components of the human T cell receptor-CD3 complex by X-ray crystallography. I
focussed on the intra- and extracellular domains of the CD3δ and CD3ε subunits. The
intracellular domains of the CD3δ and CD3ε chains were synthesised to overcome
problems inherent to the method of overexpression and the related problem of obtaining
unfolded proteins. Subsequent NMR experiments showed these synthetic peptides to be
primarily random coiled, explaining why crystallisation experiments did not (and could
not) result in crystals. Next, the external parts of the CD3δ and CD3ε chain were
overexpressed in different E. coli strains using different plasmids. Overexpression of both
components succeeded, but they could not be refolded in their active conformation.
Periplasmic overproduction of the CD3ε extracellular domain resulted in ~ 0.5 mg of
purified protein per litre of medium. At that time others published the NMR structure [23]
of the ectodomains of the CD3εγ heterodimer. Hence I shifted the focus of my research to
the interaction between CD3γ and CD3ε and the cell surface expression of the TCR-CD3
complex in human T cells, in response to mutations in CD3γ. The reported NMR structure
was used to decide which mutations in the CD3γ extracellular domain would influence the
CD3εγ binding interface and consequently the heterodimer formation. By inserting CD3γ
containing different mutations into a CD3γ-deficient T cell line three phenotypes were
obtained. One of these phenotypes was not able to express a CD3δεεγζζ complex due to a
deleterious mutation in the CD3γ-chain and therefore probably expressed a CD3δεδεζζ
complex on the cell surface. Other mutations present in the CD3γ-chain inserted into the
CD3γ-deficient T cell line resulted in a restored cell surface expression of the CD3δεεγζζ
complex, although some mutations with an impaired interaction between CD3ε and CD3γ.
A different but related subject of research was solving crystal structures of the T4
proteins in order to understand the mechanism of the adsorption of bacteriophage T4 prior
to infection by DNA injection. Understanding the host cell recognition of T4 also has
implications for development of bacteria-detection systems. This was done in
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collaboration with Stefan Miller of PROFOS AG (Regensburg, Germany). A potential
application of this research is the capture of bacteria or bacterial components e.g. LPS
(endotoxin) using columns containing tails of bacteriophage T4. Endotoxin removal is
important in avoiding artefacts and misinterpretation caused by endotoxin contamination
in highly sensitive stimulation experiments in cell culture or animal models. An important
step in this host cell recognition of the T4 bacteriophage is the attachment of the short tail
fibres to the host. These short tail fibres form inextensible stays during infection and
therewith they allow penetration of the host's cell envelope. Short tail fibres are formed by
a single protein, gp12, which form a parallel, in-register, homotrimer of 527 residues per
subunit. To investigate the host cell recognition of the bacteriophage T4, crystals were
made of proteolytic fragments of the short tail fibres containing the receptor-binding
domain. These structures revealed a surprising new fold, a knitted trimeric metal-binding
fold. Despite crystals containing LPS remaining elusive, we mapped the LPS binding site
according to the surface potential and the aromatic side-chains present on the surface of
the receptor-binding domain.
In a side project with the biotech company Pharming in Leiden, I determined the
structure of transgenically expressed human lactoferrin. Pharming reported the production
of recombinant hLF (rhLF) in the milk of transgenic cows [94] and in comparative studies
between rhLF and hLF from human milk (natural hLF) demonstrated equal biological
activities. These studies revealed identical iron-binding and release properties, and despite
differences in N-linked glycosylation, equal effectiveness in various infection models
[94]. In spite of the presence of polymorphic sides and differences in the N-linked
glycosylation, I demonstrated the three-dimensional structure of rhLF to be otherwise
identical to the structure of the human milk-derived lactoferrin.       
In collaboration with researchers at the University of Wageningen, I crystallised a
potato serine protease inhibitor (PSPI). Protease inhibitors have regained interest because
of their potent activity in preventing carcinogenesis in a wide variety of in vivo and in
vitro model systems. The PSPI is a dimeric double-headed Kunitz type inhibitor of which
no high-resolution structural data are available. The PSPI crystals diffracted to 1.8 Å and a
native data set and several derivatives could be collected. Unfortunately, molecular
replacement using different model proteins could not solve the structure. The derivatives
were found to contain insufficient number of heavy atoms. The project is therefore
ongoing.
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Summary
The human T cell receptor-CD3 complex consists of at least eight polypeptide chains:
CD3γε- and δε-dimers associate with the disulphide linked αβ- and ζζ-dimers to form a
functional receptor complex. The exact structure of this complex is still unknown. We
have now examined the interaction between CD3γ and CD3ε in human T cells. For this
purpose we have generated site directed mutants of CD3γ that were introduced in human
T cells defective in CD3γ-expression. Intracellular as well as cell surface expression of the
introduced CD3γ chains was determined as well as the association with CD3δ, CD3ε and
the T cell receptor. Three phenotypes were observed: i) the introduction of wild type
CD3γ and CD3γ(78Y-F) fully restored the T cell receptor assembly and expression; ii) the
introduction of CD3γ(82C-S), CD3γ(85C-S), and CD3γ(76Q-E) all resulted in an impaired
association between CD3γ and CD3ε and a lack of cell surface expressed CD3γ; iii) the
introduction of CD3γ(76Q-L) and CD3γ(78Y-A) restored the expression of TCR-
CD3δεγεζ2 complexes although the association between CD3γ and CD3ε was impaired.
These results indicate that several amino acids in CD3γ are essential for an optimal
association between CD3γ and CD3ε and for the assembly of a cell surface expressed
TCR-CD3δεγεζ2 complex.
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Introduction
The majority of human T cells expresses a clonotypic αβTCR heterodimer. For the
full function of the receptor, the disulphide-linked αβ-chains associate with CD3δ, CD3ε,
CD3γ and ζ. These latter form non-covalently linked δε and εγ heterodimers and
disulphide-linked ζ-ζ homodimers. While each TCR-CD3 complex thus consists of a
minimum of eight polypeptides, the exact stoichiometry of the complex is still under
discussion [1-4]. The TCRαβ, which has a Fab-like structure (Fragment antigen binding),
is responsible for the recognition of a specific antigen bound to MHC-molecules.
Subsequently, the CD3 and ζ-components mediate signal transduction and intracellular
activation [5-8]. The CD3δ, ε, and γ all have a large extracellular immunoglobulin (Ig)-
like domain, a membrane proximal stalk region, a transmembrane helix, and an
intracellular immunoreceptor tyrosine-based activation motif (ITAM) containing domain.
This is in contrast to ζ, which has a small extracellular domain and a large intracellular
domain with three ITAMs. The CD3 components are not only required for transduction of
the signal across the cell membrane, but also for the expression of the TCR heterodimers
on the surface of T cells. In the absence of one of the CD3 chains, e.g. due to a deleterious
mutation in one of them, a reduced number of T cell receptors is present on the cell
surface [9-11].
CD3 deficiencies in man are very rare autosomal disorders. In 1986, Regueiro et al
[12] reported a human CD3γ deficiency [13]. This was the first primary T cell receptor
immunodeficiency in human for which the genetic basis could be elucidated, MIM
(Mendelian Inheritance in Man) number 186740. In 1990 another deficiency (MIM
186830) followed, reported by Thoenes et al., which was later described as a CD3ε
deficiency [14-16]. Recently Dadi et al. [17] studied three cases of CD3δ deficiency. In
total three cases of human CD3γ deficiency have been published in the mutation database,
of which two are Spanish siblings, while the third patient is a Turkish male with an A to T
mutation at position 242 in his CD3γ DNA, which changes a lysine codon (AAA) to an
early stop codon (TAA) (not shown & [18]).
In 2001, Sun et al. described mechanisms contributing to T cell receptor signalling
and assembly, as revealed by the structure of the ectodomain of the murine CD3εγ
heterodimer [19]. Mutational analysis of CD3ε, focusing on the binding interface between
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CD3ε and γ, implicated several amino acids in CD3ε and γ as being important for the
domain-domain interaction. In this analysis combinations of mutations in CD3ε were
found to be required for strong effects on the association between CD3ε and CD3γ. More
recently, the structure of the human CD3εγ heterodimer complexed to the OKT3 mAb was
elucidated [20]. Small differences were observed between the human and the murine
structure, but whether these are caused by the different origins of the heterodimers (human
CD3ε and CD3γ share 41% and 43% sequence homology to their murine counterparts,
respectively) or by the different methods employed (crystallography versus NMR (nuclear
magnetic resonance)) is unknown.
In the present study we further analysed the binding interface of the CD3εγ dimer
in human T cells, by introducing mutations in CD3γ and determining the ability of such
mutated CD3γ chains to form CD3γε dimers and participate in the formation of cell
surface expressed T cell receptor-CD3 complexes. The results demonstrate that single
amino acid alterations in CD3γ can have a significant effect on the cell surface expression
of the TCR-CD3 complex and provide further evidence that αβTCRδεδεζζ complexes
can be formed even when the association of CD3εγ-dimers is impaired.
Results
Characterisation of TCR-CD3 expression on T cells of a patient with a CD3γ
deficiency
A male patient with a CD3γ deficiency is a child of parents that are first cousins.
At the age of 4 he was diagnosed with CD3γ deficiency [21]. An AAA to TAA mutation
at position 242 of CD3γ leads to an early stop codon (not shown & [18]). Because of this
mutation, the remaining transcript would encode a 46 amino acid long protein lacking
both the transmembrane region and cytoplasmic domain. PBMCs of this patient and his
healthy brother were subjected to FACS analysis (Figure 2.1A). A CD3-PE/CD4-FITC
and CD3-PE/CD8-FITC analysis indicated that the patient had diminished levels of CD3
expression on the cell surface of both T cell populations. Next, T cell lines were
established from the PBMCs of the patient, his brother and parents. At day 14 of the T cell
establishment a CD3-PE/αβ TCR-FITC analysis demonstrated that more than 96 % of the
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T cells of the healthy brother expressed an αβTCR on the cell surface, while only about 2
% of the patient' cells were αβTCR+ (Figure 2.1B).
Figure 2.1. A) The FACS analysis of double stained PBMCs of the patient (right panel) and
healthy brother (left panel). The upper panel shows the CD3/CD4 staining for patient and healthy
brother. The lower panel shows the CD3/CD8 staining. It is clearly visible that the patient had
diminished levels of CD3 expression on the cell surface of both T cell populations. B) The FACS
analysis at day 14 of the T cell establishment from PBMCs. The left panel shows the CD3/αβ-
TCR staining of the brother and the right panel shows the CD3/αβ-TCR analysis for the CD3γ
deficient patient. Only 2% of the patient's cells were αβTCR+, in contrast to 96% for the healthy
brother.
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To investigate the cell surface expression of the individual CD3γ-, δ-, and ε-chains,
the cell lines were labelled with 125I and lysed in NP40 lysis buffer. Subsequently
immunoprecipitations were carried out with CD3δ, ε and γ-specific antibodies followed
by 1-dimensional SDS-PAGE analysis (Figure 2.2). In NP40 lysisbuffer the TCR-CD3
complex dissociates into TCRαβ-, ζζ-, CD3γε- and CD3δε-dimers [22]. Consequently,
CD3γ and ε are present in CD3γ-immunoprecipitates, CD3δ and ε in CD3δ
immunoprecipitates and all three CD3 chains in CD3ε immunoprecipitates. While in the
lysates of the cell lines from the healthy brother and his parents CD3δ, ε and γ were
present and associated as expected, the lysate of the cell line of the CD3γ deficient patient
contained very little CD3δ and -ε while CD3γ was undetectable (Figure 2.2).
To verify the presence of TCR-CD3 components intracellularly, the T cell lines
were labelled with 35S-methionine/cysteine and after lysis in NP40 lysis buffer specific
immunoprecipitations were carried out with CD3γ, - δ, - ε and ζ-specific antibodies
followed by SDS-PAGE analysis. This demonstrated (Figure 2.3) that the CD3γ, δ, ε and
ζ chains were present intracellularly in the T-cell lines obtained from the parents and the
healthy brother, while the T cells of the patient contained CD3δ, ε and ζ chains at levels
comparable to the healthy controls but no CD3γ. A two-dimensional non-reducing/
reducing SDS-PAGE analysis of the ζ immunoprecipitate confirmed the normal
Figure 2.2. SDS-PAGE analyses of immunoprecipitates obtained from NP40 lysates after cell
surface iodination of T cell lines of patient, brother, father, and mother. Antisera used were
normal rabbit serum as negative control (N), anti-CD3δ (δ), anti-CD3ε (ε), and anti-CD3γ (γ),
and as reference (C) anti-HLA class I (only heavy chain is shown here, 44 kDa). The positions of
the different chains are indicated in the middle. It can be seen that the patient's cells contained
very little CD3δ and CD3ε, while CD3γ is undetectable.
50
expression of a ζ-dimer (Figure2.4). To determine the expression of the covalently linked
TCRαβ chains, immunoprecipitations were obtained with the anti-CD3ε antibody from
digitonin lysates of the metabolically labelled cells from the patient and his healthy
brother (digitonin is known to preserve the subunit interactions between the TCR and
CD3 complexes [23]). These immunoprecipitates were subjected to two-dimensional non-
reducing/reducing SDS-PAGE analysis which revealed normal intracellular expression of
the disulfide linked TCRαβ dimers in the T cells of the healthy brother and the patient
(Figure 2.4). Thus, the patient synthesises all TCR-CD3 chains except CD3γ.
Figure 2.3. SDS-PAGE analysis of immunoprecipitates obtained from NP40 lysates after
metabolic labelling of T cell lines of patient, brother, father and mother. Antisera used were
normal rabbit serum as negative control (N), anti-CD3δ (δ), anti-CD3ε (ε), anti-CD3ζ (ζ), and
anti-CD3γ (γ), and as reference (C) anti-HLA class I (only β2M is shown here, 12 kDa). The
positions of the different chains are indicated on the right. This shows that the parents and healthy
brother contain all the CD3 chains, in contrast to the patient which lacks the CD3γ chain.
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Influence of amino acid substitutions in CD3γ on assembly and cell surface
expression of the TCR-CD3 complex
Several amino acids in the binding interface between CD3γ and CD3ε have been
implicated to be important for the specific interaction between these two chains (Figure
2.5, adapted from [19]). In particular, the amino acids at position 76, 78, 82 and 85 in
CD3γ are thought to interact with amino acids in CD3ε. Mutational analysis of CD3ε has
demonstrated that multiple replacements in the binding interface are required for
abolishment of the CD3γε interactions. Such an analysis has not been performed for
CD3γ. We have now taken advantage of the availability of the T cell line of the CD3γ
deficient patient to investigate this in detail. For this purpose site directed mutants of
CD3γ cDNA were generated encoding CD3γ-chains in which the amino acids thought to
Figure 2.4. 2D (first dimension non-reducing, second reducing) SDS-PAGE analysis of anti-
CD3ε and anti-ζ immunoprecipitates. The T cells of patient (left panel) and the healthy brother
(right panel) were metabolically 35S labelled and lysates were prepared with digitonin (upper
panel) or NP40 (lower panel) lysis buffer. Antisera used were anti-CD3ε (upper panel), anti-
CD3ζ (lower panel). This demonstrates the normal expression of the ζ-dimer and αβTCR for the
patient compared to the healthy brother.
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be important for the interaction with CD3ε are substituted by either homologous or non-
homologous amino acids (see Table 2.1). These CD3 constructs, as well as wild type
CD3γ, were stably introduced into the patient's T cell line together with the reporter gene
GFP as described [24,25] and GFP+ cells were selected by FACS-sorting. These GFP+ T
cell lines and the control patient T cells were analysed for expression of the TCR-CD3
complex by FACS analysis using a CD3ε specific antibody. Moreover, the intracellular-
and cell surface expression of the CD3γ, δ, ε-chain and the interaction between these
chains were determined by SDS-PAGE analysis of CD3δ, CD3ε and CD3γ
immunoprecipitates carried out with 35S-labeled and 125I-labeled cell lysates of the cell
lines, respectively.
Three phenotypes were observed. First, the introduction of wild type CD3γ fully
restored the CD3γε interaction and TCR-CD3 expression (Figure 2.6, and Table 2.1 for
summary). Similarly, the introduction of CD3γ in which the tyrosine at position 78 is
replaced for a phenylalanine (78 Y-F) resulted in restoration of CD3γ protein expression,
CD3γε interaction and TCR-CD3 expression. We therefore conclude that the 78 Y-F
mutation allows the expression of a TCR-CD3δεγεζ2 complex on the cell surface. In
contrast, the 82 C-S (Figure 2.6, see Table 2.1 for summary), 85 C-S and 76 Q-E
mutations (not shown, see Table 2.1 for summary) gave rise to a different phenotype. In
Figure 2.5. Schematic overview of the CD3εγ binding interface. The important residues are
represented by their one-letter amino acid code and their corresponding residue number,
followed by the specific monomer. The right figure, which is a zoom-in of the left picture, is
adapted from [12]. The figures were prepared with MOLSCRIPT  [26] and Raster3D [27].
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all these cases apparent normal cell surface expression of the TCR-CD3 complex was
observed but no CD3γ was observed on the cell surface and, consequently, no interaction
between CD3γ and CD3ε was detectable (Figure 2.6). To determine if the mutated CD3γ-
chain is synthesised, immunoprecipitation with the CD3γ specific antibody were carried
out using 35S-labeled lysates of the transfectants. The results indicate that CD3γ is
synthesised (Figure 2.7) but that it can not associate with CD3ε since the αβTCR and
CD3ε could not be detected in the CD3γ specific immunoprecipitates carried out with
DIG lysates. These results show that CD3γ is expressed intracellularly, but is not capable
to associate with the CD3ε chain in order to form a cell-surface αβTCR-CD3δεγεζ2
complex. Finally, the 76 Q-L and 78 Y-A mutations gave rise to a third phenotype: while
CD3γ protein was present in the cell surface expressed complex (Figure 2.6, see Table 2.1
for summary), the association with CD3ε was impaired since no CD3γ could be detected
in the CD3ε immunoprecipitate. Longer exposures also failed to show the presence of
CD3γ (not shown). The presence of CD3γ on the cell surface, however, indicates that
these cells do express TCR-CD3δεγεζ2 complexes.
Table 2.1. Analysis of CD3γ expression, heterodimer formation and subsequent TCR-CD3 complex
cell surface expression of the different mutations, wild type and the patient.
mutation 76Q-E 76Q-L 78 Y-F 78 Y-A 82 C-S 85 C-S wt patient
phenotype 2 3 1 3 2 2 1
γ intra n/a n/a n/a + n/a + + (b) -
γ cell surface - * + ++ + - - ++ -
εγ cell surface - +/- ++ +/- - - ++ -
εδ cell surface + + ++ + + + ++ +
complex cell
surface εδεδ εγεδ εγεδ εγεδ εδεδ εδεδ εγεδ εδεδ
* If the level of CD3γ or CD3εγ is denoted as “-“, it is possible that undetectable amounts are
present at the cell surface, n/a = not analysed, wt = wild type, full CD3γ inserted, b = brother was
used as reference for a healthy person. Phenotype 1 = fully restored TCR assembly and expression,
2 = impaired association between CD3γ and CD3ε and lack of cell surface expressed TCR-
CD3δεγεζζ complex, and 3 = restored CD3δεγεζζ complexes although impaired association
between CD3γ and CD3ε.
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Figure 2.6. A) SDS-PAGE analysis of immunoprecipitates obtained from NP40 lysates after cell
surface iodination of patient and the cells contain the CD3γ with different mutations. Antisera
used were, anti-CD3δ (δ), anti-CD3ε (ε), and anti-CD3γ (γ) and anti HLA class I (c, only heavy
chain is shown). Analysis of the WT was done in a different experiment causing differences in
autoradiography time and radioactivity of 125I. To show that the 78Y-F mutation has the same
expression levels compared to the WT, the 78Y-F is shown twice, once with the WT (lower
panel) and once with all phenotypes (upper panel). B) Histograms of patient and mutant GFP+ T
cells. Unstained cells are represented by a white histogram, and cells after staining with anti-
CD3-PE are represented by a black histogram. The abscissa gives the fluorescence intensity in a
logarithmic scale, the ordinate gives the relative cell number.
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Discussion
The interaction of the T cell receptor with its MHC-peptide ligand is a crucial step
towards the initiation of adaptive immune responses. Due to the short cytoplasmic tails of
the T cell receptor α- and β-chains, however, these can not transduce the signal over the
cell membrane. This is accomplished by the T cell receptor associated CD3γ, -δ, -ε and ζ-
chains. The mechanism by which this is performed is still an ill understood process.
Although several studies have indicated that the minimal T cell receptor-CD3 complex
contains 8 chains, αβTCR-CD3δεγεζζ, the exact stoichiometry of the complex is still not
clear, nor is the way in which all the individual components are arranged in the complex.
A NMR study has for the first time provided information on the structure of part of the
extracellular domains of a murine CD3γε-complex [19]. In this study several amino acids
located in the interface between CD3ε and CD3γ were implicated as being important for
the association. Mutational analysis of residues in the stalk region of CD3ε indicated that
combinations of mutations were required for disturbing the interaction of CD3ε with
CD3γ. We have now generated mutants of CD3γ and stably introduced these in T cells
from a patient with a deleterious mutation in the CD3γ gene, resulting in aberrant TCR-
Figure 2.7. SDS-PAGE analysis of immunoprecipitates obtained from NP40 and DIG lysates
after 35S metabolic labelling of CD3γ mutants. Antisera used were, anti-CD3δ (δ), anti-CD3ε
(ε), and anti-CD3γ (γ). The positions of the different chains are indicated on the right. This
shows that CD3γ is expressed intracellularly even in mutants that lack cell surface CD3γ
expression (85 C-S).
56
CD3 expression. TCR-CD3 complexes in such a patient are most likely composed of
TCR-CD3δεδεζζ complexes instead of TCR-CD3δεγεζζ as has been previously
suggested by Geisler [28] and Pérez-Aciego et al. [10]. In agreement with previous
studies we find that the reconstitution with wt CD3γ completely restores the cell surface
expression levels of the TCR, CD3δ, CD3ε, and CD3γ [9,29]. In contrast, replacement of
either one of the two cysteine residues in the proximal stalk region of CD3γ to serine
abrogates the interaction between CD3ε and CD3γ. This is in disagreement with Sun et al.
[19] who suggested that these conserved cysteines in the stalk region facilitate the CD3εγ
pairing but are not required for the association of these CD3 chains.
The CD3γ (78 Y-F) mutation did not effect the CD3γε association and thus led to
the cell-surface expression of the TCR-CD3δεγεζζ complex comparable to that observed
with wt CD3γ. A striking result is that 3 mutations, 82 C-S, 76 Q-E, and 85 C-S all
resulted in cell surface expression of the TCR-CD3 complex equivalent to the cells
expressing wt CD3γ but in the apparent absence of detectable amounts of CD3γ itself as
evidenced by a lack of (co)immunoprecipitation with the CD3ε and the CD3γ specific
antibody. Intracellularly, however, the expression of these mutated CD3γ chains could be
detected as shown for mutant 85 C-S. It is known that the large majority of intracellularly
synthesised TCR and CD3 chains are degraded before they can be assembled in a
functional TCR-CD3 complex [30]. Possibly a weak interaction of mutant CD3γ with
CD3ε limits the rate of degradation of CD3ε and leads to a higher cell surface expression
of a TCR-CD3δεδεζζ complex compared to the CD3γ deficient patient, as has been seen
by FACS analysis. Alternatively, the culture conditions may have selected transfectants
expressing a higher number of receptors on their cell surface. Irrespective of this, our
results demonstrate the importance of the two cysteine residues in the proximal stalk
region for the association between CD3γ and CD3ε.
Finally, the CD3γ (76Q-L) and CD3γ (78Y-A) mutations led to intracellular
expression and transport of CD3γ to the cell surface, presumably in a TCR-CD3δεγεζζ
complex, in spite of an undetectable association with CD3ε. This result indicates that a
tight association between CD3γ and CD3ε is not required for normal expression of an
intact TCR-CD3 complex.
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From the crystal structure of the CD3εγ heterodimer complexed with the mAb
OKT3 [20] we can make two assumptions about the impact of the CD3γ mutations. First,
the 76Q to E mutation excludes the possibility of hydrogen-bond formation at position Q
76Oε1. However, since all the other interactions, including main-chain hydrogen bonding
(see Table 3 of [20]) at the interface will be maintained, it can be concluded that the
hydrogen bond formation at Q 76Oε1 is very important for the heterodimer formation.
Second, the 78Y to F mutation has little impact on the hydrogen bond pattern and the Van
der Waals interactions, resulting in a normal association of the heterodimer. This in
contrast to the replacement of 78Y to A mutation, which does change the Van der Waals
interactions with Leu90Cδ1, Leu92Cδ1 and Val16Cβ, Cγ1, Cγ2 of CD3ε (see Table 3 of [20]).
This loss of Van der Waals interactions explains the observed loose interaction of CD3εγ.
In conclusion, our results have identified amino acids in the extracellular domain
of CD3γ to play a key role in the association between CD3γ and CD3ε which is a
prerequisite for the cell surface expression of TCR-CD3δεγεζζ complexes.
Materials and Methods
PBMC isolation and establishment of T cell lines
PBMC were isolated from heparinised blood obtained from patient, his parents and
a healthy older brother, by Ficoll density gradient centrifugation. For the generation of T
cell lines, PBMC (5 x 106) were cultured in the presence of allogeneic, irradiated (3000
rad) PBMC (10 x 106), 50 U/ml rIL2 (Chiron, Amsterdam, The Netherlands) and 5 µg/ml
PHA (Murex Diagnostics, Dartford, UK) in RPMI 1640 (Gibco) supplemented with 2 mM
glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 10 % FCS (Gibco). Twice
weekly half of the supernatant was replaced by fresh medium containing 50 U/ml rIL2
and once in a period of three weeks allogeneic, irradiated PMBC were added. After a
culture period of 2 months the doses of rIL2 was enhanced to 100 U/ml and cells were
harvested a month later.
Derivatisation of mutants and construction of retroviral vectors
A bicistronic vector, LZRSpBMN-linker-IRES-GFP, was used as described in
Heemskerk et al.  [24] with the gene of interest linked to a downstream internal ribosomal
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entry site (IRES) and a marker gene (Green fluorescent protein, GFP) that allows
independent translation of the products of both genes in the transduced cells. The vector
was adapted for the gateway cloning system (Invitrogen, Breda, The Netherlands). Site
directed mutagenesis was performed using the polymerase chain reaction according to
Landt [31] using a CD3γ cDNA clone [32] as template with custom-made primers. The
mutations were made at AA-position 78, tyrosine (TAT) was changed to a phenylalanine
(TTT) and an alanine (GCT), at AA-position 76 where the glutamine (CAA) was mutated
to a glutamate (GAA) or a leucine (CTA), and at AA-position 82 and 85 where the
cysteines (TGT) where mutated to serines (TCT). The resulting PCR products were
cloned into the vector and clones were confirmed by automated fluorescent sequencing.
Generation of retroviral supernatant and retroviral transduction
Phoenix cells, a 293T-based amphotropic retroviral packaging cell line [25] were
transfected via the calcium phosphate precipitation method (Life Technologies,
Gaithersburg, MD, USA), after 2 days 2 µg/ml puromycin (Clontech, Palo Alto, CA,
USA) was added. At 10-14 days after transfection, 6 x 106 cells per 10 cm2 petridish were
plated (Beckton Dickinson, Meylan, France) in 10 ml IMDM supplemented with 10 %
FBS without puromycin. After 24 hours the medium was refreshed and at the following
day retroviral supernatant was harvested, which was frozen at –70 °C. Non-tissue culture
treated plates (Beckton Dickinson, Meylan, France) were coated with retronectin (Takara,
Shiga, Japan) for two hours at room temperature. Then, the coated wells were blocked
with 2 % human serum albumin (CLB, Amsterdam, the Netherlands). T cells were added,
and after 30 minutes culture medium was removed, and thawed retroviral supernatant was
supplemented. Viral supernatant together with cells were incubated overnight, followed
by washing, and finally transferred to cell culture bottles in normal tissue culture medium.
After 3 days, transduced cells were sorted by fluorescence-activated cell sorting on a
FACSVantage (Becton Dickinson, Mountain View, CA, USA) on basis of high level GFP
expression. After several weeks of culture, the GFP+ populations of the several mutant T
cells were used for the experiments.
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Cell culturing
Patient cells and the mutant cells were cultured in Iscove's modified Dulbecco's medium
(IMDM, Gibco BRL) supplemented with 3 mM glutamine, 10 % normal human serum
(NHS) and 100 U rIL2/ml. Medium was refreshed every three days and the cells were
restimulated every 10-14 days with 100 U rIL2, 1 µg/ml PHA and 10 x 106/ml irradiated
(2500 rad) PMBC, as feeder cells.
Antibodies
The antibodies against CD3δ, CD3ε, and CD3γ were all rabbit antibodies and
directed against peptides corresponding to the Carboxy termini of the human CD3 chains,
The anti-CD3ζ serum was raised against the predicted N-terminus of the human ζ chain as
has been described before [33]. The anti-HLA class I antibody (W6/32) [34], which was
used as a control, is a mouse monoclonal antibody.
Cell surface iodination and metabolic labelling
For cell surface iodination 10 x 106 cells were washed three times in PBS and
resuspended in 30 µl lactoperoxidase (250 U/ml, Sigma-Aldrich) solution. 1 mCi Na125I
(NEN) was added to the cells followed by the addition of 10 µl 0.05 % H2O2/PBS (Sigma-
Aldrich) with 5 minutes intervals. After the labelling was stopped and the free iodine was
removed by washing the cells three times with 500 µl 2 mM KI/PBS, the cells were
solubilised in 750 µl lysisbuffer containing 0.5 % NP40 (Sigma-Aldrich) and protease
inhibitors (Complete, EDTA-free tablets, Roche Diagnostics). After 30 minutes
incubation on ice, the lysates were centrifuged 15 minutes (13000 x g) at 4 °C. For 35S
metabolic labelling, 7 x 106 vital cells were washed with 10 ml RPMI without methionine
and cysteine, centrifuged and resuspended in 10 ml of the same medium. Cells were
incubated for 30 minutes at 37 °C / 5% CO2, centrifuged and the resulting pellets were
resuspended in 10 ml RPMI without Met/Cys, 100 U/ml IL2 and 1 mCi 35S Met/Cys.
After 4 hours incubation at 37 °C / 5% CO2 cells were centrifuged and washed twice with
PBS. The cells were solubilised in 750 µl lysisbuffer containing 0.5 % NP40 or 1 %
digitonine, and protease inhibitors. After 30 minutes incubation on ice, the lysates were
centrifuged 15 minutes (13000 x g) at 4 °C.
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Immunoprecipitation and SDS-PAGE analysis
The lysates, after labelling with 125I or 35S, were precleared by adding 100 µl
protein A sepharose CL4B (PAS beads, Amersham Pharmacia Biotech) gently shaking at
room temperature followed by the addition of 75 µl normal rabbit serum, and shaken at
room temperature for one hour. After the removal of the beads, specific
immunoprecipitations with CD3δ, CD3ε, CD3ζ, CD3γ antibodies, normal rabbit serum
(NRS) or anti-HLA class I were performed by adding 5 µl antiserum (2 µl for anti-HLA
class I) to 100 µl precleared lysate (1D SDS-PAGE) or 200 µl precleared lysate (2D SDS-
PAGE) for 60 minutes at room temperature. The PAS beads were washed four times with
500 µl lysis buffer and resuspended in 100 µl 1x sample loading buffer (20 mM Tris-HCl,
pH 6.8, 0.01% bromophenol blue, 1% SDS, 10% glycerol, 1% β-mercaptoethanol) and
analysed on a reducing 12 % SDS-PAGE. For 2 dimensional SDS-PAGE, the PAS beads
were resuspended in loading buffer without 2-mercaptoethanol, and loaded onto the first
non-reducing 12% cylindrical-gel. After the first dimension, the gel was incubated for 10
minutes in Laemmli buffer with β-mercaptoethanol and placed on top of the reducing
second dimension 12 % SDS-PAGE gel. After drying of the gels autoradiography was
performed at –80 °C using Kodax or Fuji scientific imaging films.
Fluorescence activated cell sorter (FACS) analysis
For single stained cells, the cells were washed with PBS/0.5 % BSA and labelled
with mouse anti-human anti-CD3-PE (Becton/Dickinson) at 4 °C for one hour. Followed
by washing with PBS/0.5 % BSA and fixating with 0.5 % paraformaldehyde. In the case
of CD3/CD4 and CD3/CD8 double staining, the cells were stained with anti-human anti-
CD3-PE and washed with PBS/0.5 % BSA and labelled with mouse anti-human anti-
CD4-FITC or anti-CD8-FITC antibody. For CD3/αβ-TCR double staining cells were
stained with anti-human anti-CD3-PE and washed with PBS/0.5 % BSA, followed by
labelling with non-directly conjugated anti-αβ-TCR antibody for one hour at 4 °C. After
washing the cells were stained with GAM-FITC antibody, washed and fixated.
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2.2
Analysis of intracellular CD3δ and CD3ε synthetic
peptides
Summary
The T cell receptor-CD3 complex contains at least eight chains, the disulphide- linked αβ
TCR, and the associating CD3γε, CD3δε and ζ2 dimers. The structural information on
these components is limited. This is not due to problems with crystallography or NMR,
these techniques got better over the years, but to problems of expressing and isolating the
different chains, heterodimers or the whole TCR-CD3 as such. To overcome these
problems, synthetic peptides corresponding to the intracellular domains of CD3δ and
CD3ε were synthesised. Crystallisation and NMR studies were performed in order to
determine the three-dimensional structures. Unfortunately, crystallisation experiments for
CD3δ only produced "sea urchin" type of crystals of poor quality and micro- or macro
seeding did not give diffracting crystals. Folding experiments using NMR show that the
synthetic peptides are primarily random coiled.
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Introduction
Synthetic peptides were synthesised corresponding to the cytoplasmic domains of
the CD3δ and CD3ε. The CD3δ is 44-mer, with a molecular weight and a calculated pI of
4995.38 Da and 6.93, respectively. The CD3ε is a 55-mer, with a molecular weight and a
pI of 6179.03 Da and 11.52, respectively. These intracellular domains are quite distinctive
in their charge. It is thought that the intracellular domains bind to form a heterodimer in
the TCR-CD3 complex.
Results
Crystallisation
In order to determine the three-dimensional structure of the intracellular domains
of CD3δ and CD3ε crystallisation experiments were performed. The peptides were
dissolved in water at various concentrations (2.5-25 mg ml-1). Different Hampton screens
were set up by mixing equal volumes of 1µl reservoir solution and protein solution.
Unfortunately, none of these conditions resulted in the formation of suitable crystals.
After several rounds of macro- and micro seeding for the CD3δ peptide, the best that was
obtained were "sea urchins" (Figure 2.8).
No set up for CD3ε peptide resulted in any crystal or sea urchin formation. The
CD3ε peptide has a high pI and Hampton screens are not available in the higher pH range
(around 11) so a screen was made in this pH range. Unfortunately this did also not initiate
any crystal formation. A possible explanation for the lack of crystal formation is that both
the peptides are (partially) unfolded.
Figure 2.8. Sea urchins of CD3δ intracellular
peptide (25mg/ml) in a hanging drop-vapour
experiment. The reservoir solution contains
1.2M ammonium sulphate at pH 5.5.
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Folding and binding studies on CD3δ and CD3ε peptides using NMR
In order to determine whether the synthetic peptides used in the crystallisation
experiments are folded, NMR experiments were performed. The synthetic peptides were
dissolved in water, at a concentration of approximately 1mM. The pH was adjusted to 5.6
and 6.2 for CD3δ and CD3ε, respectively. Of both intracellular peptides a 1D proton
NMR spectrum (Figure 2.9) was recorded at 298 K on a Bruker DMX-600. The spectra of
the single peptides show poor dispersion and narrow line width. Therefore it was
concluded that the peptides are primarily random coil.
After these experiments, the peptides were mixed and left for 30 minutes at room
temperature. A 1D proton NMR was recorded (Figure 2.9), the spectrum of the combined
peptides was a superimposition of the two spectra of the single peptides, leading to the
conclusion that no interaction or folding could by measured in this NMR experiment.
Therefore further experiments on these domains were abandoned.
Discussion and conclusion
Both the CD3δ and CD3ε synthetic peptides have no internal structure shown by
1D proton NMR and are therefore unable to form crystals. Mixing the two synthetic
peptides did not change the delta-positions of the peaks in the 1D proton NMR spectrum.
The combined spectrum is a superimposition of the two spectra of the single peptides,
therefore it was concluded that the peptides did not interact at the given experimental
conditions. Mixing the peptides does not result in folding of the individual peptides,
prohibiting significant interaction between the intracellular domains. Whether the lack of
folding and binding of the two peptides after mixing is caused by the absence of the
transmembrane and/or extracellular domains or by the fact that the single peptides were
primarily unfolded is unknown.
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Figure 2.9. 1D proton NMR of CD3δ and CD3ε intracellular synthetic peptides and the CD3δε
mix at 298K. Poor dispersion and narrow line width leading us to conclude that no interaction or
folding could by measured in this NMR experiment.
3Bacteriophage T4
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Summary
Adsorption of T4 bacteriophage to the Escherichia coli host cell is mediated by six long
and six short tail fibres. After at least three long tail fibres have bound, short tail fibres
extend and bind irreversibly to the core region of the host cell lipo-polysaccharide (LPS),
serving as inextensible stays during penetration of the cell envelope by the tail tube. The
short tail fibres consist of a parallel, in-register, trimer of gene product 12 (gp12). X-ray
crystallography at 1.5 Å resolution of a protease-stable fragment of gp12 generated in the
presence of zinc chloride reveals the structure of the C-terminal receptor-binding domain.
It has a novel "knitted" fold, consisting of three extensively intertwined monomers. It
reveals a metal-binding site, containing a zinc ion coordinated by six histidine residues in
an octahedral conformation. We also suggest an LPS-binding region.
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Introduction
Bacteriophage T4 is a very efficient DNA injection machine [1], consisting of a
DNA-containing head, a double-tubed tail of which the outer tail-sheath is contractile, and
a base-plate to which six long tail fibres and six short tail fibres are attached. The long tail
fibres recognise the outer membrane protein C (OmpC) protein or LPS of E. coli B and
are responsible for the initial, reversible, attachment of the virion. After at least three long
tail fibres have bound, the baseplate changes conformation from the "hexagon" form to
the "star" form [2]. In the hexagon form, the short tail fibres are incorporated in the
baseplate in bent fashion, as shown by cryo-electron microscopy [3]. Upon conversion of
the baseplate to the star form, the short tail fibres extend and bind irreversibly to the core
region of the host cell LPS [4]. Here they form inextensible stays, allowing penetration of
the cell envelope by the baseplate "hub" and tail tube upon contraction of the outer tail-
sheath [3]. When gene product (gp12) is absent, baseplates spontaneously convert to the
star form [5] and 12- phages have the unusual property of contracting without releasing
their DNA upon reversibly adsorbing to cells [6].
Short tail fibres are composed of a single protein, gp12 [7] forming a parallel, in-
register, homo-trimer of 527 residues per subunit. They are attached to the baseplate via
their N-termini, while the C-terminal globular domain has been proposed to bind to the
bacterial host cell [8], although to our knowledge no mutation or deletion experiments
have been reported to prove this. Correct folding into trimers of gp12 requires the
chaperone protein gp57 [9]; gp12 trimers are incorporated into the baseplate as one of the
last steps, together with gp9 [10]. Gp12 resists dissociation by sodium dodecylsulphate
(SDS) at room temperature and monomerisation requires heating of the polypeptide
chains [11].
Previous structural studies by electron microscopy [8] show gp12 to form an
elongated trimeric complex with a slender shaft (24 nm x 4 nm) capped by an arrow-
shaped, more globular domain (11 nm x 6 nm). Estimates of its mass by scanning
transmission electron microscopy confirmed the trimeric nature of the protein. These
studies also show that the gp12 trimer is frequently bent roughly halfway its length, a
feature consistent with its folded-away state in the baseplate.
Previously a 33 kDa proteolytic fragment generated in the presence of EDTA [12]
was crystallised. This fragment consisted of residues 85-396 and 518-527. However, in
the crystal structure [13] residues 85-245 were invisible due to static disorder. The ordered
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residues, 246-396 and 518-527, revealed three new folding motifs. Residues 246-289 form
an N-terminal region, held together by intertwined strands and a central, mainly
hydrophobic core. Residues 290-327 form a central right-handed triple-stranded β-helix,
which is connected to the "collar" domain by three short α-helices (residues 333-341).
The collar is formed by three small globular domains, each containing amino acid residues
343-396 and 518-527 and consisting of six β-strands and an α-helix in a hitherto unseen
topology.
By omitting EDTA and adding divalent zinc ions during proteolysis we could
ensure that amino acids 397-517 remained part of the complex upon limited proteolysis,
resulting in a 45 kDa fragment. Here, we report the structure of this C-terminal domain at
1.5 Å resolution and show that it is the receptor-binding domain.
Results and Discussion
Preparation of a proteolytic 45 kDa fragment of the bacteriophage T4 short
tail fibre
The gp12 full-length protein was co-expressed with its chaperone gp57 [9] and
purified. The purified protein was incubated at 56 °C and subsequently treated with
proteases in the presence of divalent zinc ions. SDS-PAGE (not shown) revealed that a
fragment of around 45 kDa was obtained, instead of a 33 kDa fragment that is generated
in the presence of EDTA [12].  N-terminal sequence analysis (results not shown) showed
that both the 45 kDa and 33 kDa fragment start at residue Leu85. The 33 kDa fragment,
however, lacks amino acid residues 397-517. Inclusion of these residues leads to a
predicted mass of 47072 Da; therefore, we assumed that the 45 kDa fragment contains
amino acid residues 85-527 of native gp12, without the internal deletion of residues 397-
517 of the 33 kDa fragment.
Crystallisation and structure determination
Crystals of the 45 kDa fragment of gp12 with unit cell dimensions of 50.78 x 50.78
x 435.6 Å, grew under the same conditions as those of the 33 kDa fragment [12]. Both
proteins crystallised in space group P321 with similar short a and b cell axes. However,
the long c cell axis of the 45 kDa fragment is substantially larger, the crystal contacts are
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different and the crystals are not isomorphous. The crystals contain one molecule in the
asymmetric unit (i.e. one-third of a trimer), have a solvent content of 64 % (v/v) and a
Wilson temperature factor of 14 Å2.
Molecular replacement trials using the known structure of residues 246-396 plus
518-527 of the 33 kDa fragment (PDB-code 1H6W [13]) were not successful, so two
datasets of a single-site mercury derivative were collected and the structure was
determined by single isomorphous replacement using the anomalous signal. Both
derivative crystals had virtually identical mercury content, and although the structure
could most likely have been elucidated with just one derivative dataset, we decided to
include both as they were of similar quality (see Table 3.1). The resulting map showed
good electron density for residues 330-527 (see Figure 3.1), but not for residues 85-329.
Nevertheless, we confirmed residues 85-329 to be present in the crystal by SDS-PAGE of
crystals washed in mother liquor (results not shown). As we knew the structure of residues
246-334 from the crystal structure of the 33 kDa fragment of gp12, we included these in
the model in a refinement trial. However, even adding just five extra residues to the N-
terminus of the model led to lower agreement with the measured data. As none of the
residues 85-329 could be refined satisfactorily, they were probably not well ordered in the
crystal.
The Hg-derivatised amino acid was found to be Cys372. In the 33 kDa fragment
both Cys362 and Cys372 were derivatised, but in the 45 kDa fragment solvent access to
Cys362 appeared to be prevented by the extra domain consisting of residues 397-517.
Having solved the structure, we repeated molecular replacement trials using just residues
330-397 and 518-527 from the 33 kDa fragment structure [13]. This led to the correct
solution, so with hindsight the structure could also have been determined by molecular
replacement, had we guessed that in crystals of the 45 kDa fragment residues up to 329
were disordered.  The final model of the monomer contains 198 residues of 443 present in
the asymmetric unit. The final model had good stereochemistry and low R-factors (Table
3.1) and contains 1560 protein atoms, a zinc ion on the threefold axis, two sulphate ions,
one citric acid molecule and 512 water molecules in the asymmetric unit (Table 3.1).
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Figure 3.1. Structure of the ordered region of the proteolytic fragment of gp12 generated in the
presence of zinc ions. (a) Stereo-view of part of the crystallographic electron density. Amino
acids Gly397 (top), Leu398, Phe399, Val400, Arg401, Gly402, Ser403 and Gly404 (bottom) are
shown in ball-and-stick representation surrounded by the final 2Fo - Fc electron density map
contoured at 1.5σ. (b) Stereo-view of the structure. In the blue monomer, every 20th residue is
labelled. The other monomers are coloured red en green. The N-terminal "neck" is at the bottom,
the "collar" domain in the middle and the C-terminal receptor-binding domain at the top. Figures
1, 2, 4 and 6 were prepared with BOBSCRIPT [14], which is based on MOLSCRIPT [15]. For a
colour picture see appendix A.
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Table 3.1. Crystallographic data and refinement statistics
                                         Native                           Derivative set1                 Derivative set2
A. Data collection
Beam-line ESRF ID29 ESRF BM14 ESRF BM14
Wavelength (Å) 0.946 0.867 0.867
Detector ADSC Q4R 130 mm MAR CCD 130 mm MAR CCD
Resolution range (Å) 15.0-1.5 99-2.74 99-2.73
(1.58-1.50)a (2.83-2.74) (2.83-2.73)
Multiplicity 6.6 (3.1) 5.6 (3.3) 6.1 (2.2)
Completeness (%) 89.8 (53.3)b 98.0 (90.4) 96.6 (78.0)
Rsymc (%) 10.6 (28.4) 8.6 (13.1) 9.9 (18.9)
B. Phasing
Number of Hg-sites 1 1
Phasing powerd,f (centric/acentric) 2.70 / 1.61 2.61 / 1.57
Rcullise,f (centric/acentric) 0.53 / 0.57 0.54 / 0.59
C. Refinement
Resolution range (Å) 15.0-1.50 (1.58-1.50)
No. of reflections used in refinement 94341 (6339)
No. of reflections used for R-free 1922 (116)
R-factorg 0.143 (0.20)
R-free 0.152 (0.22)
No. of protein / water atoms 1560 / 512
Average B-value protein / solvent (Å2) 16.8 / 42.7
Ramachandran statisticsh (%) 84.9 / 15.1 / 0.0 / 0.0
R.m.s. deviationsi (bonds, Å / angles, °) 0.018 / 1.6
a Values in parentheses are for the highest resolution bin, where applicable.
b Data in the higher resolution shell are less complete because of data collection on a square
detector.
c Rsym = Σh Σi |Ihi - <Ih>| / Σh Σi | Ihi |, where Ihi is the intensity of the ith measurement of the same
reflection and <Ih> is the mean observed intensity for that reflection.
d Phasing power = ( |FH| / ||FPH| - |FP + FH|| ), where FH, FPH and FP are the heavy atom, derivative
and native structure factors, respectively.
e Rcullis = ( ||FPH| - |FP + FH|| ) / ( ||FPH| - |FP|| ).
f Phasing statistics were produced with MLPHARE [16].
g R = Σ||Fobs(hkl) | - |Fcalc(hkl) || / Σ|Fobs(hkl) |.
h According to the program PROCHECK [17]. The percentages are indicated of residues in the most
favoured, additionally allowed, generously allowed and disallowed regions of the Ramachandran
plot, respectively.
i Estimates provided by the program REFMAC [18].   
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Electron microscopy of the 45 kDa fragment of gp12
To further characterise the crystallised 45 kDa fragment, we performed electron
microscopy and three-dimensional reconstruction on negatively stained protein from
dissolved crystals (see Figure 3.2(a)) and compared the resulting three-dimensional maps
to those of full-length protein and the 33 kDa fragment obtained before [12]. This showed
that, compared with the full-length protein, the 45 kDa fragment only misses an N-
terminal region, while the 33 kDa fragment misses an additional C-terminal domain
(Figure 3.2). We did not attempt a very precise and high-resolution reconstruction as we
already had the crystal structure. However, the reconstruction was of sufficient quality to
assign the polarity of the fibre without ambiguity and to place the atomic model in the
electron microscopy map, even if some pseudo-symmetrisation may have taken place
along the long axis of the fibre.
Previously, the C-terminal domain was shown to have an arrow-shaped form [8],
but in our electron microscopy reconstruction it has a more bi-lobed peanut shape. The bi-
lobed shape is also observed in our previous reconstruction of full-length gp12 and is
probably due to some internal flexibility, which smeared out the density at both ends of
the particles. A space-filling representation of our current crystal structure shows a shape
in between these two extremes: a bi-lobed shape in which the extreme lobe is more
slender. The flexibility of the 45 kDa fragment appears to be more pronounced than that
of the 33 kDa fragment and full-length protein, also leading to the disappearance of some
ordered density at the N-terminal side compared to the 33 kDa fragment.
Bacterial cell binding of the 45 kDa and 33 kDa fragment
As it is generally assumed that the C-terminal domain is involved in LPS-binding,
we investigated whether the 33 kDa and 45 kDa fragments behaved differently in binding
to bacterial cells. To measure cell-binding activity, proteins were immobilised in micro-
plate wells and were allowed to bind to bacteria. Unbound bacteria were washed off and
bound bacteria were detected by their intrinsic beta-galactosidase activity (Figure 3.3).
Full length gp12 and the 45 kDa fragment were both capable of binding to bacteria, while
the 33 kDa fragment did not bind, showing that the receptor-binding domain was absent
from the 33 kDa fragment but present in the 45 kDa fragment. Full-length gp12 appeared
more active than the 45 kDa fragment in binding, which may be explained by the
hydrophobic virus-binding N-terminus of full length gp12. The hydrophobic parts having
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a higher affinity for the micro-plate wells may have led to more C-terminal domains being
exposed to the solution.
In summary, the activity data indicated that the most important receptor-binding
residues are contained in the C-terminal region removed upon proteolysis in the presence
of EDTA but are retained upon proteolysis in the presence of zinc. This region, containing
residues 397-517, are therefore referred to as the receptor-binding domain.
Figure 3.2. Crystal structures fitted into their corresponding electron microscopy maps. (a) Part of
a field of negatively stained 45 kDa fragment fibres from a dissolved crystal. The size of the field is
75 x 75 nm. (b) Averaged three-dimensional negative stain electron microscopy map of the 33 kDa
fragment with the structure of ordered region of the 33 kDa fragment fitted into it [9]. (c) Averaged
three-dimensional negative stain electron microscopy map of the 45 kDa fragment with the
structure of ordered region fitted into it (this work). (d) Averaged three-dimensional negative stain
electron microscopy map of full-length gp12 with a composite structure of the ordered regions of
the 33 and 45 kDa fragments fitted into it. The composite structure was constructed by
superimposing residues 340-395 and 520-527, present in both the 33 kDa and 45 kDa fragments.
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Overview of the structure
The structure can be divided into two parts, the part already present in the
previously reported structure of the 33 kDa fragment [13], and the previously unresolved
receptor-binding domain (Figures 3.2(c) and 3.4). The first can be further sub-divided into
a "neck" and "collar", while the latter can be further sub-divided into a "head" and
"bonnet" (see below). We refer to the triple alpha-helix of residues 333-341 as the neck,
connecting the body of the fibre (unresolved in this structure) to its C-terminal collar and
receptor-binding domains. Amino acid residues 342-396 plus 518-527 form the collar,
whilst residues 397-517 form the extensively intertwined receptor-binding domain (Figure
3.4).
The surface area of the monomer in our structure is 16800 Å2, of which 9900 Å2
(58 %) is buried in the trimer. This large proportion of buried surface explained the
extraordinary stability of the trimer, which does not dissociate into monomers in SDS-
PAGE  without boiling (for more information on the stability of gp12 see ref. 14).
The collar domain
The collar domain is a small globular domain containing six beta-strands and an
alpha-helix (bottom of Figure 3.4(b)) with a weak structural homology with bacteriophage
T4 gp11 [19] as described before [13]. The six beta-strands form a sandwich of two three-
Figure 3.3. Assay of bacterial cell-binding of gp12 and its proteolytic fragments. Shown is
fluorescence caused by hydrolysis of methylumbelliferyl-beta-galactoside due to E. coli
bacteria bound to immobilised gp12 at the concentrations indicated on the x-axis. See Materials
and Methods for further details. Circles, full-length gp12; triangles, 33 kDa fragment missing
N-terminal and C-terminal domains and squares, 45 kDa fragments missing only N-terminal
domains.
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stranded anti-parallel beta-sheets (bottom of Figure 3.4(c)). When the main-chain atoms
of the collar domain (residues 342-395 and 520-527) from the current structure were
superimposed on those of the smaller 33 kDa fragment, they overlapped very well with a
root-mean-square displacement of 0.5 Å for the monomer and 0.7 Å for the trimer.
Differences of more than one Å were limited to a few residues at the top of the collar.
Presumably, the absence of the receptor-binding domain in the smaller fragment was the
cause of these differences. Of each monomer in the collar domain, a relatively modest
1200 Å2 (27%) of its surface area is buried. The collar domain is the only domain in
which the three monomers are not intertwined. This observation suggests that folding of
the T4 short tail fibre may start with this domain (see below).
Legend to Figure 3.4 which is on the next page
Figure 3.4. Structure of the ordered region of the 45 kDa fragment. (a) Space-filling model of the
structure illustrating the extensive intertwining in the receptor-binding domain. (b) Ribbon
diagram in the same orientation as (a). At the bottom the neck region (the alpha-helical residues
336-339), in the middle the collar region (residues 340-396 plus 518-527) and at the top the
metal-containing receptor-binding domain (residues 397-517), divided into head and bonnet as
described in the text. (c) Topology diagram. Alpha-helices are marked I, II and III, beta-strands A
to Q (excluding I) and Z. Begin and end residues of the secondary structure elements are
numbered in one of the monomers (not always the same one to avoid overlaps). Grey boxes
surround the six-stranded beta-barrel domain and the other, smaller beta-sheets. In the three-
dimensional structure, the blue loops marked with a * connect, as do those marked **. With a
small thought experiment the reader can convince him- or herself that the structure is knitted
rather than knotted: move the green JKL-strands to the left under the red OP-strands, then lift to
the right over the red OP-strands. Do this for all three monomers and the "knit" is resolved. For
colour picture see appendix A.
81
82
The receptor-binding domain: head and bonnet
The receptor-binding domain as a whole can be compared to a flower bud with 12
petals in 3-fold symmetry. At the bottom, residues 406-432 form the first petal, just above
that residues 489-504 form a second petal, above that residues 450-470 a third and at the
top a fourth petal consisting of residues 470-480 is present. The three JQF beta-sheets
(Figure 3.4(b) and (c)) form a base and the rest of the amino acids are all in more or less
extended conformation at the centre of the trimer (Figure 3.4). In the receptor-binding
domain, the strands are knitted together in a highly complex fashion and 7400 Å2 (60%)
of the surface area of the monomer is buried in the trimer. The receptor-binding domain
can be sub-divided into "head" (residues 397-446 and 487-517) and "bonnet" sub-domains
(residues 447-486), with a metal-binding site on the border between the two.
The receptor-binding domain has hardly any regular secondary structure elements
like alpha-helices or beta-stands, despite 90% of its main chain torsion angles being in
most favoured regions of the Ramachandran plot and none being in the generously
allowed or disallowed regions (according to PROCHECK [17]). Many inter-domain
hydrogen bonds (main-chain - main-chain, main-chain - side-chain and side-chain - side-
chain) stabilise the trimeric protein structure. At the top of the head domain, in the central
region of the trimer, a metal ion, presumably zinc, is octahedrally coordinated by Nε2 of
six histidine residues (His445 and His447 from each monomer).
Residues 397-403 form an extended strand transverse to the fibre axis, contributing
Leu398, Phe399 and Val400 to the hydrophobic core and Arg401 and Ser403 to the
outside of the molecule. The strand is followed by a long "loop" (404-432), buffeting
against the core of the molecule (the first petal of the flower bud). In some respects the
loop resembles a beta-hairpin, but regular beta-strand contacts are rare and there are
deviations and inserted structures, like a distorted helix (amino acids 406-414). N404 and
O404 form hydrogen bonds with O432 and N431, respectively, while hydrogen bonds are
also present between O414 and N426, O416 and N424 and N418 and O422. Residues 418
to 421 form a non-classical reverse turn. At the end of this petal is another reverse turn,
with Gly435 at position i + 3. This turn is followed by an extended region going upwards,
consisting of residues 436-450 and containing the metal-binding histidine residues 445
and 447 (see below).
Just above the metal-binding site, residues 447-450 together with 482-486 form a
highly distorted anti-parallel beta-barrel-like structure (the OPOPOP-sheet) in the trimer;
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and together with the connecting regions (451-481) they form the bonnet. Main-chain -
main-chain hydrogen bonds are found between the main-chain oxygen of residue 447 and
the main-chain nitrogen of residue 484 of a second subunit, between N449 and O482 of
the same second subunit and between O448 and N485 of a third subunit and between
N450 and O483 of the same third subunit. The residues above this structure are knotted
together, but because they are de-knotted again in the domain underneath, overall the
trimer is knitted rather than knotted (see Figure 3.4(c)). Residues 450-470 form a loop
capped by a reverse turn (458-461), encircling residues 478-484 of a neighbouring
monomer.
Residues 470-472 form a small two-stranded beta-sheet with residues 474-476 of a
neighbouring monomer. Inter-chain hydrogen bonds are present between N470 and O476,
O470 and N474 and N472 and O474. The residues in between, Arg472 and Lys473, form
short loops at the top of the molecule, making the top positively charged (see below).
Residues 480-488 form an extended strand downwards at an angle of around 45°,
traversing near the centre of the trimer (Thr484), culminating in the second petal, a loop
of residues 489-504. Residues 492-496 form a small distorted helix in this loop. The
following residues (506-517) meander downwards towards the collar domain, encircling
amino acids 439-443 of a neighbouring monomer.
The central trimer axis is mainly hydrophobic, in the collar domain with
contributions from Val331, Val332, Ile341, Met347 and Met348 (from bottom to top). In
the receptor-binding domain amino acids projecting side chains towards the central trimer
axis are Phe399, Pro514, Thr512, His445, His447 (the latter two forming the metal-
binding site), Thr484, Phe451, Thr471 and Lys472, again from bottom to top.
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The LPS-binding site
The binding site for the LPS core region is currently unknown, although our
proteolysis experiments show that it is contained in the domain consisting of residues 397-
517. Based on the chemical nature of LPS core, we can make some suggestions. Figure
3.5(a) shows the primary structure of the LPS core region, consisting of sugar residues
with attached phosphate groups. We can assume phosphate groups bind to positive
charges on the protein surface while the sugars bind to aromatic side-chains [20-23].
Figure 3.5(b) shows the electronic surface potential of the protein, while in 5(c) the
aromatic side-chains are mapped on the surface. The trimer in general, and its top in
particular, is positively charged, which could contribute to its affinity for the negatively
charged E. coli membrane. Symmetrically along the sides of the trimer there are three
grooves which are flanked by, or contain positively charged residues and aromatic amino
acids. Two solvent molecules, a citric acid and sulphate ion, form salt bridges with
Arg465 and Arg464, respectively, perhaps mimicking LPS core phosphate groups. We
suggest that each of these grooves may bind an LPS molecule, analogous to the
adenovirus fibre binding to three receptor molecules at once [24]. This would lead to very
tight binding and a very low off-rate, especially if we consider that six short fibres can
bind simultaneously to the E. coli membrane, each through three receptor binding sites.
This also would fit to the observation that binding of the short fibres to the bacterial cell in
the second host recognition step renders the modus from a reversible to an irreversible (or
at least quasi-irreversible) attachment of the phage [1]. The sequence of the homologous
bacteriophage T4-like strain AR1 [25] has 64 % overall and 63 % receptor-binding
domain identity and provides additional clues. Assuming the short tail fibre of this phage
also binds to the same LPS core molecule, we could eliminate some residues from
consideration, as their basic or aromatic character is not conserved in AR1 gp12. This
would leave the basic putative LPS-binding residues Lys446, Lys422, Arg504, Arg424,
Arg513 and the aromatics Tyr454, Phe451, Trp477, Phe468, Phe460, Phe420, Tyr488,
Tyr444, His408 and Tyr433. The basic residues cluster in a region behind the bottom
petal, suggesting it may function as a kind of LPS clamp. The putative aromatic receptor-
binding residues are more scattered (Figure 3.5(b) and (c)).
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Of course, we cannot rule out other amino acids being important for binding, a
conformational change taking place upon LPS core binding or an alternate mode of
receptor binding by the short tail fibre of strain AR1. Nevertheless, the suggested residues
are a starting point for site-directed mutagenesis and / or other biochemical experiments to
elucidate the location of the receptor-binding site. We are pursuing crystal soaking and co-
crystallisation experiments with LPS core analogues to obtain structural information, but
so far these have not yielded useful data (Chapter 3.2).
Figure 3.5. Possible LPS binding residues. (a) Primary structure of the LPS of E. coli B core
region plus lipid A. Glc stands for glucose, GlcN for glucosamine, Hep for heptose, P for ortho-
phosphate and KDO for 2-keto-3-deoxyoctonate. (b) Electronic surface potential diagram of the
trimer. Positive charges are marked in blue, negative in red. Putative receptor binding basic amino
acids (see text) are labelled. Please note that although the five labelled residues appear to cluster in
two groups, they are in fact all five very close to each other due to the 3-fold symmetry. (c) Surface
diagram showing in green aromatic side-chains that may be involved in LPS binding. Labels
identify the amino acids. Figures 5 (b) and (c) were made with the program GRASP [26] with the
protein in the same orientation for both. The protein is shown tilted forwards to afford a better view
of the top of the trimer. Residues are labelled by their one-letter amino acid code. For colour
picture see appendix A.
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The metal
In the centre of the receptor-binding domain, on the 3-fold axis, we found a metal
ion, octahedrally coordinated by the Nε2 of His445 and His447 from each monomer
(Figure 3.6). An X-ray fluorescence scan of the crystal used for data collection at beam-
line ID29 of the ESRF confirmed the metal ion to be zinc, which was anticipated, as zinc
chloride was used in the preparation of the 45 kDa proteolytic fragment (see Material and
Methods). The zinc ion inside the gp12 trimer confirms data of Zorzopulos & Kozloff
[27], indicating gp12 to be a zinc metallo-protein. They estimated gp12 to contain one
zinc atom per monomer. In our structure, we found one zinc atom per trimer (although we
cannot exclude other zinc binding sites in the parts of gp12 missing from our structure).
Further experiments are required to determine the gp12-zinc stoichiometry and to show
whether other metals can substitute for zinc in the protein. Preliminary results suggested
that divalent calcium, manganese and copper ions can substitute for zinc ions in the
proteolysis experiments to obtain the 45 kDa fragment, while magnesium ions led to a 33
kDa fragment similar to the one obtained with EDTA (Thomassen et al., unpublished
results).
The Zn ion is well-ordered with a temperature factor of 7 Å2 and also the
coordinating residues are present in well-defined conformations with temperature factors
of between 6 and 8 Å2. The refined distances of the zinc ion to the Nε2 of His445 and
His447 are 2.22 and 2.25 Å, respectively. These distances are larger than found normally
for zinc coordination by histidine [28]. A possible explanation lies in the octahedral
coordination of the zinc in our structure. In protein structures solved so far, zinc is
coordinated tetrahedrally [28]. The His445 Nε2 - zinc - His445 Nε2 angles are around
90.5°, while His447 Nε2 - zinc - His447 Nε2 angles are around 89°. The His445 Nε2 -
zinc - His445 Nε2 angles are around 87, 94 and 175°, i.e. very close to perfect octahedral
coordination. There is no evidence for alternate conformations of the zinc ion or its
ligands in the electron density.
As the bacteriophage T4 short tail fibre does not appear to have enzymatic activity,
unlike the P22 tailspike [29], the role of the zinc ion is probably purely structural. Zinc
clearly increases the stability of the C-terminal part of gp12 against proteases, but may
also increase the stability of the C terminus in general.
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Comparison with known protein structures
A search of the protein structure database using the program DALI [30] with the
structure of amino acids 397-517 did not show up any related structure, while the collar
domain has some limited structural homology with the central domain of T4 gp11 [13].
There are, however, some proteins of unknown structure which show limited sequence
similarity. A BLAST search [31] using residues 330-527 found the collar region to be a
putative conserved domain in a microcystin dependent protein (mdpB), of which the
function is not known [32].  We also discovered similarities with several lambda prophage
side tail fibre protein homologues from the E. coli genome [33] and the Rhizobium protein
RhiB, a protein proposed to be involved in interactions of Rhizobium with its plant host
[34]. In all cases most homology was with the collar domain, although in the case of RhiB
a putative His-Xaa-His (His-Ala-His in this case) metal-binding "motif" could be
identified C-terminal to the homologous region. As the functions of these proteins remain
to be fully elucidated, the possibility that they are just inserted phage genes cannot be
ruled out.
Homology was also detected with the bacteriophage long tail fibre protein gp37
[35], which, apart from binding to OmpC, also binds to E. coli B LPS [1]. Again, most
homology was found within the collar domain, with several His-Xaa-His motifs C-
terminal to the homologous sequence. Further homologues that turned up were fibre
Figure 3.6. The zinc ion in the centre of the receptor-binding domain. Shown are the main chains
of the three monomers (residues 443-448 in each case) in yellow, red and green and the side-
chains of the ligating histidine residues. The coordination is octahedral with a Zn-His445 Nε2
distance of 2.22 Å and a Zn-His447 Nε2 distance of 2.25 Å. For angles see the text. (a) Side
view. (b) View from the top down the three-fold axis. (c) View down one of the four-fold axes of
the octahedron formed by the Nε2 atoms of the six ligating histidine residues. For colour picture
see Appendix A.
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proteins from other bacteriophages; some of these proteins also contained His-Xaa-His
sequences C-terminal to their putative collar domains. Further biochemical and structural
experiments will reveal whether these homologues also contain metal ions.
The disordered region
The inability to visualise residues 85-329 remained puzzling, but was also
observed for the smaller 33 kDa fragment [13], in which residues 85-245 are invisible.
Furthermore, adding the known structure of residues 246-329 to the model led to a worse
model, indicating the region was really disordered, or, but this we consider unlikely, has a
different structure in the larger fragment. The nature of the disorder is unknown, but the 3-
fold symmetry of the protein suggests that perhaps crystal contacts with the next layer
may be made in three different, symmetrically equivalent, ways. As the disordered,
fibrous region of the structure is thinner than the globular C-terminal collar and receptor-
binding domains (see Figure 3.2), there may be enough space within the crystal lattice for
these contacts to be distributed randomly around the three possibilities, smearing out
crystallographic electron density. To visualise the fibrous domains at high resolution, it
may be necessary to crystallise artificial constructs in which the globular domains are
replaced by a smaller trimerisation domain like the bacteriophage T4 fibritin "foldon"
[36].
Folding of the C-terminal domain of gp12
From the structure, it seems probable that the collar domain may act as a folding
nucleus, as it is the only domain in which the three monomers do not intertwine. Upon
trimerisation of this domain, the remaining C-terminal receptor-binding domain and the
N-terminal domains can then intertwine. As the zinc ion occupies a central position in the
receptor-binding domain, it seems likely zinc (or other metal) ions play a role in its
folding, although successful refolding experiments were also done in presence of 1 mM
EDTA [9]. Perhaps gp12 competed effectively with EDTA for zinc. In vivo, the molecular
chaperone gp57 is necessary for folding of gp12 (as well as for the long tail fibre proteins
gp34 and gp37), although the mechanism for this chaperone action is not known. Data
from refolding experiments suggests that addition of gp57 suppresses unproductive side-
reactions of refolding gp12. Based on the structural data presented here, we would suggest
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gp57 may act in keeping the unfolded gp12 monomers apart until the collar domains
trimerise, preventing aggregation.
Domain swapping in the receptor-binding domain?
The intertwining or knitting of the receptor-binding domain (residues 397-517)
could also be considered as a particular case of three-dimensional "domain swapping"
(reviewed by Rousseau et al. [37] and Liu et al. [38]), in which residues 399-472,
containing beta-strands F-M and alpha-helix III have been "swapped" to the neighbouring
monomer (or, which is equivalent, where residues 474-519, containing beta-strands N-Q,
have swapped to the neighbour on the other side), leading to cyclic trimerisation.
However, we do not know of a homologous protein where the receptor-binding
domain is a monomer, or of a homologous bacteriophage short tail fibre where the
receptor-binding domain is not intertwined. Also, the extent of inter-monomer contacts in
the receptor-binding domain and in the N-terminal and triple-stranded beta-helix domains
makes it unlikely that the monomer exists other than as a very unstable folding
intermediate. Therefore, we do not know if the domain evolved as an intertwined domain
from its origins or whether at some time during its evolution three-dimensional domain
swapping took place. In this respect it is interesting to note that the collar domain shows
some limited structural homology to a domain of gp11 [19] (explained by van Raaij et al.
[13]), the protein to which it binds in the baseplate, raising the possibility that gp12
evolved from gp11, which does not show domain swapping.
Perspectives
The structure presented in this thesis is an important step towards understanding
the molecular details of receptor-binding of bacteriophage T4 and suggests experiments to
determine the receptor-binding site and mechanism. It also reveals a surprising new fold.
The as yet unsolved structures of the bacteriophage T4 long tail fibre proteins and fibres
of other viruses may turn up more surprises.
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Material and Methods
Expression and purification of gp12
For expression of full length gp12, the plasmid pT4g57g12  was transformed into
E. coli strain JM109(DE3) (Promega) and cultures (total volume 4 litre) were grown to
A600 nm = 0.6-1.0. Cultures were cooled to 22 °C or below, expression was induced by
addition of 1 mM IPTG and carried out overnight at 16 °C. Cells were harvested by
centrifugation, resuspended in 100 ml of cold TE-buffer (40 mM Tris-HCl pH 8.0, 10 mM
EDTA) containing 0.2 M ammonium sulphate and lysed using a French press. After
centrifugation, ammonium sulphate was added to the soluble fraction to 0.8 M and some
impurities were pelleted by centrifugation.
The supernatant was brought to 1.4 M ammonium sulphate, precipitating gp12.
After centrifugation, the gp12 precipitate was re-dissolved in 50 ml of TE-buffer
containing 0.8 M ammonium sulphate and loaded onto a 75 ml high substitution phenyl
Sepharose column (Pharmacia), which was equilibrated with the same buffer. The protein
was eluted with a gradient of 0.8 M to 0 M ammonium sulphate in TE-buffer, gp12 elutes
at around 200 mM ammonium sulphate. The gp12 containing fractions were pooled (total
volume 120 ml), ammonium sulphate was added to a final concentration of 1.8 M,
precipitating gp12. The precipitated gp12 was stored as a suspension at 4 °C.
Proteolysis experiments
The precipitated gp12 in 1.8 M ammonium sulphate was pelleted by centrifugation
and re-dissolved in 20 ml of HN-buffer [10 mM N-(2-hydroxyethyl)piperazine-N’-(2-
ethane) sulphonic acid-sodium hydroxide, 150 mM sodium chloride, pH 7.4] containing
10 mM zinc chloride. The sample was incubated for 30 minutes at 56 °C and cooled to 37
°C, 10 mg trypsin and 10 mg chymotrypsin powder (Sigma) were added and the sample
was incubated for 20 minutes at 37 °C. The heat and trypsin/chymotrypsin treatment was
then repeated. The sample was purified by gel-filtration on a Pharmacia Sephacryl S200
column which was equilibrated with TE-buffer containing 200 mM sodium chloride, the
fractions that contained the 45 kDa fragment were pooled (total volume 37 ml),
precipitated with ammonium sulphate (final concentration 1.8 M) and stored at 4 °C.
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Electron microscopy
Electron microscopy of the 33 kDa fragment and full-length gp12 has been
described [12]. Micrographs of 45 kDa fragment from crystals dissolved in HN-buffer
were taken the same way; the protein at a concentration of about 0.1 mg/ml was
negatively stained with sodium silicotungstate at pH 7.0. The bending of the 45 kDa fibre
showed more variation than for the 33 kDa fragment or the full-length gp12. The three
best images of the sample were digitised on Zeiss scanner (Photoscan TD) with a pixel
size of 14 µm (3.5 Å at the sample scale). Six hundred particles were manually selected
from the corresponding images and boxed into 128 x 128 pixels square boxes using
Ximdisp [16]. All particles were band-pass filtered between 200 and 25 Å without
contrast transfer function correction and then normalised to the same mean and standard
deviation. Processing was done using the SPIDER image-processing package [39]. We
generated a starting model by back-projecting one fibre and by applying the known three-
fold symmetry along the axis of the fibre. This model was re-projected along the axis
perpendicular to the three-fold axis every 15 degrees covering the asymmetric unit (120°).
The raw images were aligned against the re-projections by cross-correlation and then
averaged inside their corresponding image classes. The eight class averages were then
used to calculate a new three-dimensional reconstruction of the fibre by back projection.
After 20 cycles of this procedure, the reconstruction parameters were stable. The
resolution of the final reconstruction was estimated by Fourier shell correlation to be
around 45 Å.
Crystal structures were fitted into the averaged electron microscopy maps using the
fast Fourier transform accelerated six-dimensional exhaustive search module (COLORES)
of the program SITUS [40]; default values for all parameters were used.
Bacterial cell binding assay
To generate the 33 kDa fragment for cell-binding analysis, limited proteolysis of
gp12 (1 ml) was performed in the presence of 10 mM EDTA as described [12] at 37 °C
after partial unfolding at 56 °C by adding trypsin (80 µl of a 10 mg/ml solution). After a
second trypsin addition to achieve homogenous proteolysis, a sample of the reaction
mixture was analysed using SDS-PAGE. The 45 kDa fragment was generated the same
way, but in presence of 10 mM zinc chloride and absence of EDTA.
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The 33 kDa and 45 kDa fragments were subsequently purified by gel filtration
chromatography on a Superdex 75 preparation grade matrix (Amersham Biosciences,
Uppsala, Sweden) using PBS-buffer (10 mM sodium phosphate pH 7.4; 150 mM sodium
chloride). Fractions containing the 33 kDa and 45 kDa fragments were analysed using
SDS-PAGE, pooled and concentrated by ammonium sulphate precipitation as described
above.
To analyse the bacteria-binding capabilities of the 33 kDa and 45 kDa fragments in
comparison to native gp12, a cell binding assay was performed. Various amounts of the
proteins in 100 µl PBS-buffer were immobilised in wells of micro-plates (Nunc Maxisorb
Fluorescence, Nunc, Roskilde, Denmark) by passive adsorption for 12 h at 37 °C. Excess
material was removed by washing the wells three times with 200 µl of PBS. Bound
protein was measured by anti-p12 rabbit antibody (kindly provided by York-Dieter
Stierhof and Ulf Henning, Max-Planck-Institut für Biologie, Tübingen) and anti-rabbit
IgG-alkaline phosphatase conjugate (Sigma, St. Louis MO, USA). For cell-binding
assays, wells were incubated with 100 µl of a tenfold diluted, IPTG-induced stationary
culture of E. coli D21. After incubation for one hour at 25 °C unbound bacteria were
removed by washing three times with 200 µl PBS supplemented with 0.5 % Tween 20
(Sigma, St. Louis MO, USA). Bound bacteria were detected by measuring their intrinsic
beta-galactosidase activity with the fluorescence substrate methylumbelliferyl-beta-
galacoside (Sigma, St. Louis MO, USA) as described by Davies et al. [41].
Crystallisation
The ammonium sulphate-precipitated 45 kDa fragment was re-dissolved in HN-
buffer to a final concentration of 10-20 mg/ml. Protein concentrations were determined
using UV absorption measurements at 280 nm; the absorption of a 1 mg/ml solution of
gp12 or its proteolytic 45 kDa fragment was assumed to be 1.0 at a path-length of 1 cm.
Crystals of the fragment were obtained by vapour diffusion against reservoirs containing
15-35 % (v/v) tertiary butanol buffered with 100 mM sodium citrate at pH 5.6 and in the
presence of 0-10 % (v/v) glycerol. Single crystals of up to 0.1 x 0.1 x 0.5 mm were
obtained. Crystals were transferred to 10 % (v/v) glycerol in crystallisation buffer for data
collection if necessary.
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Crystallographic data collection and processing.
Native data were collected on beam-line ID29 at a wavelength of 0.946 Å at the
European Synchrotron Radiation Facility (ESRF). The crystal was flash-frozen and kept at
100 K during data collection. The crystal had a mosaic spread of 0.255°. The total rotation
angle was 180° (360 images of 0.5°). Reflections were integrated with the programme
MOSFLM [42] and processed using programs of the CCP4 suite [43]. Measurements
differing more than 6 standard deviations from the weighted mean were rejected (180 of
629124 measurements or 0.03 %). For data statistics see Table 3.1. For collection of
derivative data, crystals were soaked overnight in methylmercury acetate. Datasets to 2.8
Å resolution of two crystals soaked in methylmercury chloride were measured at the
BM14-UK MAD beam-line at the ESRF at a wavelength of 0.867 Å (Table 3.1). Data of
the derivative data was processed using HKL2000 [44]; the statistics can also be found in
Table 3.1.
Structure solution and refinement
One mercury site was identified by the SOLVE programme [45], using data
between 20 and 2.8 Å. The position, occupancy and temperature factor of the sites were
refined and phasing was done also using SOLVE. Solvent flattening and automated
building of a partial model proceeded using RESOLVE [46] and data between 20 Å and
2.2 Å. When input into the ARP-WARP auto-trace mode [47] using data to 1.5 Å
resolution, a model resulted containing residues 335 to 526. Rebuilding of the model and
addition of extra amino acid residues (330-334 and 527) was done with O [48].
Refinement was done using the REFMAC programme [18]. Water molecules were built
using ARP [49].
Coordinates. Coordinates and structure factors have been deposited in the Protein Data
Bank (accession codes 1OCY and R1OCYSF, respectively).
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3.2
Crystallisation and preliminary crystallographic studies of a
new crystal form of the bacteriophage T4 short tail fibre
Summary
Six long and six short tail fibres mediate adsorption of T4 bacteriophage to the
Escherichia coli host cell. After at least three long tail fibres have bound, short tail fibres
extend and bind irreversibly to the core region of the host cell lipo-polysaccharide (LPS),
serving as inextensible stays during penetration of the cell envelope by the tail tube. The
short tail fibre consists of a parallel, in-register, trimer of gene product 12 (gp12). Parts of
the structure of the short tail fibre were determined before, the so-called 33 kDa and 45
kDa fragments, of which the latter contains the receptor-binding domain (see chapter 3.1
of this thesis). None of these structures had ordered electron density for about half of the
amino acid residues, although we did confirm their presence in both crystals by N-
terminal sequencing. Here we present a partial structure of a new crystal form of the 45
kDa fragment, which contains all the residues present in the 33 kDa and 45 kDa fragment
(amino acids 246 to 527), and also shows low resolution electron density for the residues
invisible in the structure described in chapter 3.1 (some or all of the amino acids 85-245).
The structure presented here confirms the hypothesis of the composite structure of the
ordered regions of the 33kDa and 45kDa given in chapter 3.1 Figure 3.2d.
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Introduction
Previously, a 33 kDa proteolytic fragment was generated in the presence of EDTA
(ethylenediaminetetra-acetic acid) and crystallised [1]. This fragment consisted of residues
85-396 and 518-527, however in the crystal structure [2] residues 85-245 were invisible
due to static disorder. By omitting EDTA and adding divalent zinc ions during proteolysis
we could ensure that amino acids 397-517 are included in the so-called 45 kDa fragment
[3]. The 45 kDa fragment contains the C-terminal receptor-binding domain however,
residues 85-329 are absent. The amino acids 330-396 and 518-527 were the only residues
visible in both the 33 kDa and 45 kDa fragments. See Figure 3.7 for an overview of both
structures.
Here we report a new crystal form of a proteolytic fragment of gp12. This crystal
form was obtained in experiments performed to determine the binding location of the LPS
to the short tail fibre receptor-binding domain (for further details on the receptor-binding
domain see Chapter 3.1). Unfortunately no LPS did bind to the receptor-binding domain,
however, a different crystal form was obtained. This crystal form has a larger part of the
electron density ordered, amino acid residues 246-527 have clear electron density. For
amino acid residues 85-245 that were not visible at all in the earlier determined structures,
low resolution electron density is now present. The N-terminal domain of full length gp12
contains six times the same 17-residues sequence repeat [2]. One of these repeats (amino
Figure 3.7. The crystal structures of the
33 kDa (PDB 1HW6) and 45 kDa (PDB
1OCY) fragments. The corresponding
amino acids and domains are depicted on
the right.
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acids 255-271) is present in the well ordered part of the 33 kDa structure so we searched
for the other remaining repeats in the less ordered electron density via molecular
replacement. Three possible repeats were found but did not really improve the density or
Rfactors. Unfortunately the low resolution electron density is not ordered enough to
enable building of any of the amino acids 85 to 245.
Results
Protein purification
The gp12 full-length protein was co-expressed with its chaperone gp57 and
purified as has been described before, see chapter 3.1 of this thesis and ref. 3. The purified
protein was incubated at 56 °C and treated with proteases in de presence of divalent zinc
ions. SDS-PAGE revealed that a fragment of around 45 kDa was obtained. The protein
(further referred to as the 45kDa fragment) was precipitated with ammonium sulphate and
stored at 4 °C until further use.
Crystallisation and structure determination
The ammonium sulphate precipitated 45 kDa fragment was re-dissolved in HN-
buffer (10 mM N-(2-hydroxyethyl)piperazine-N"-(2-ethane) sulphonic acid-sodium
hydroxide, 150 mM sodium chloride, pH 7.4) to a concentration of 10-20 mg/ml. Protein
concentrations were determined using UV absorption measurements at 280 nm; the
absorption of a 1 mg/ml solution of the 45kDa fragment was assumed to be 1.0 at a path-
length of 1 cm. In order to determine where the lipo-polysaccharide binds on the short tail
fibre receptor-binding domain, crystallisation trials were set up in the presence of LPS.
The LPS from E.coli mutant D21f1 was isolated and purified according to Boman &
Monner and Prehm et al. [4,5]. Crystals of the 45 kDa fragment were obtained by vapour
diffusion (at 295 K) against a reservoir solution containing 35 % (v/v) tertiary butanol
buffered with 100 mM sodium citrate pH 5.6, 10 % (v/v) glycerol, and LPS (see Figure
3.8). The exact LPS concentration was difficult to determine due to the presence of
impurities. The crystallisation conditions are the same as described in chapter 3.1 [3].
However, the protein crystallised in a different space group, R32, with single crystals
growing as hexagon-shaped plates (Figure 3.8).
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Data collection and processing
Native data were collected on beam-line ID29 at a wavelength of 0.9756 Å at the
European Synchrotron Radiation Facility (ESRF). The crystal was flash-frozen and kept at
100 K during data collection. The total rotation angle was 269° (538 images of 0.5°).
Reflections were integrated with the program MOSFLM [6] and processed using
programs of the CCP4 suite [7]. The 45 kDa fragment crystallised in the rhombohedral
space group R32 with unit cell parameters a = b = 45.49, c = 1376.97 Å (hexagonal
setting). The overall completeness of this data set was 79.0 %, with a completeness of
54.1 % in the highest resolution bin (2.42 - 2.30 Å). Data in the higher resolution shell are
less complete because of the data collection on a square detector. The overall
completeness is rather low, because the long axis was parallel to the beam, causing many
overlaps. The overall redundancy and Rsym were 10.4 and 0.080, respectively. The crystals
contain 1 molecule in the asymmetric unit (i.e. one-third of a trimer), have a solvent
content of 57.5 % (v/v) and a Wilson temperature factor of 36 Å2. Data collection and
processing details are summarised in Table 3.2.
Structure solution and refinement
Molecular replacement trials using the known structure of residues 246-396 plus
518-527 of the 33 kDa fragment (PDB-code 1H6W [2]) and the residues 330-527 of the
45 kDa fragment (PDB-code 1OCY [3]) gave a solution with an Rfactor of 0.58 and a
correlation coefficient of 0.237. Rigid body refinement by REFMAC [8] using 19833
reflections resulted in an Rfactor of 0.443 and an Rfree of 0.447, for the resolution range
of 40 to 2.3 Å. Amino acids 246-284 were removed from the refinement because these
were not well ordered. Restrained refinement was carried out using REFMAC [8]. The top
of the molecule appears to be somewhat rearranged and the amino acid residues 469-476
Figure 3.8. Crystals of the short tail fibre
protein in the presence of LPS. The protein
crystallised in space-group R32.
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were rebuilt manually using O [9]. Several restrained refinement runs including amino
acid residues 280-284, and manually rebuilding amino acid residues 246-279, resulted in
an R-factor and Rfree of 0.31 and 0.36, respectively. An overview of the partial structure
is shown in Figure 3.9. A mask was built using SOLOMON [10] and density modification
was performed using SOLOMON and DM [11]. Despite the fact that a well-defined mask
was obtained, the density modification was ineffective. At 4 Å resolution there is density
visible for the remaining N-terminal residues 85-245, but it is not straightforward to build
them.
Table 3.2. Data collection and processing statistics. Data statistics of the outer resolution shell (2.42
- 2.30 Å) are given in parentheses, where applicable
Data collection 45kDa fragment in space group R32
Crystal dimensions (mm) 0.2 x 0.2 x 0.05
Wavelength (Å) 0.9756
Resolution range (Å) 76.70 - 2.30
Crystal system Rhombohedral
Space group R32
Unit cell parameters (Å) a = b = 45.49, c = 1376.97
Total No. reflections 215985
No. unique reflections 21737
Multiplicity 10.4 (5.1)
Rsyma 0.080 (0.26)
Completeness (%) 79.0 (54.1)
Average I/σ(I) 5.9 (2.7)
Solvent content (%) 57.5
VM (Å3 / Da) 2.9
a Rsym = Σh Σi |Ihi - <Ih>| / Σh Σi |Ihi| , where Ihi is the intensity of the ith measurement of the same
reflection and <Ih> is the mean observed intensity for that reflection
In an attempt to build extra residues, a two-dimensional search was done with the
program AMORE maintaining residues 279-527 (the most well-ordered amino acids)
fixed, and translating and rotating residues 255-271 (one sequence repeat) in small
intervals (0.001 x cell-axis c and 3º, respectively) along z, which is the three-fold axis of
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the crystal and of the trimeric structure. This way, apart from the original 255-271 repeat,
three more possible repeats were found which looked to fit reasonably into the density.
However, incorporating the respective amino acid changes followed by refinement did not
really improve the density or the Rfactors (the minimum Rfactor obtained was 0.31 with
an Rfree of 0.35).
Discussion and future prospects
The short tail fibre (gp12) of bacteriophage T4 crystallised into an other space
group (R32) as before (P321), having more of the density ordered in the crystals
compared to the two partial structures determined earlier [2,3]. A view of the partial
crystal structure is shown in Figure 3.9. This structure contains amino acid residues 246-
527, which can be divided in the "body" (246-332), "neck" (333-341), "collar" (342-396
and 518-527), "head" (397-446 and 487-517), and "bonnet" (447-486). The metal binding
site, which has a zinc-ion on the 3-fold axis, is between the "head" and the "bonnet" as
before [3]. We could not identify extra electron density located near to the receptor-
binding domain; therefore it appears no LPS has bound.
Amino acid residues 330-527 of the 1OCY structure were superimposed with the
residues 330-527 of the structure described here, using LSQKAB from the CCP4 program
suite [7]. This showed that the top region of the receptor-binding domain, the "bonnet",
has minor differences in the main-chain positions for the residues 469-476 (Figure 3.10).
Whether the differences in main-chain position of residues 469-476 are caused by the
difference in crystal contacts or by the LPS present in the crystallisation conditions, is not
known.
Figure 3.9. Crystal structure of short tail fibre (gp12) of bacteriophage T4, amino acid residues
246-527. The head and bonnet form the receptor-binding domain. A grey sphere represents the
zinc ion present on the 3-fold axis. The picture was prepared with MOLSCRIPT [12].
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The Rfactors suggest that there is still improvement possible in the missing
unsolved domain of residues 85-245. Because we were not able to build these residues
into the electron density map, and solvent flattening did not improve the electron density
map, a possibility would be to improve the phases using data collection on heavy atom-
derivatised crystals. From the structure determined before [2,3], we know that the 45 kDa
fragment of gp12 has at least one residue (Cys372), which can react with methylmercury
acetate, this residue is solvent accessible in the crystals as well. Hg-derivatisation as done
for the 45 kDa fragment may therefore be a good strategy to try to improve the phases.
Collecting a native data set with the long axis of the crystal almost parallel to the rotation
axis would improve the completeness of the native data set.
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Figure 3.10. Superposition of the Cα atoms (amino acid 468-477) of a part of the "bonnet"
for the two gp12 trimers in different space groups. a) Top view on the bonnet along the three-
fold axis. Both gp12 trimers in different colours, R32 (blue) and P321 (green). b) Rotated
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was made with PyMOL [13]. For colour picture see Appendix A.
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Summary
Interest in protease inhibitors has been renewed because of their potent activity in
preventing carcinogenesis in a wide variety of in vivo and in vitro model systems. Potato
tubers contain a wide range of such protease inhibitors. In cv. Elkana potato tubers,
protease inhibitors represent about 50 % of the total amount of soluble protein. Potato
Serine Protease Inhibitor (PSPI), one of the isoforms of the most abundant group of
protease inhibitors, is a dimeric double-headed Kunitz-type inhibitor. No high-resolution
structural information on this type of inhibitor has so far been obtained, as all structures
currently known are of the monomeric single-headed or monomeric double-headed types.
Crystals were grown in 0.1M HEPES pH 7.5, 10 % PEG8000 and 8 % ethyleneglycol
complemented with 9 mM 1-s-octyl-β-D-thioglucoside or 0.1 M glycine. Data were
collected from a single crystal under cryo-conditions to 1.8 Å resolution. The protein
crystallises in space-group P21, unit cell parameters a = 54.82, b = 93.92, c = 55.44 Å and
β  = 100.7°; the scaling Rsym is 0.044 for 45456 unique reflections.
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Introduction
The majority of known and characterised protease inhibitors are serine protease
inhibitors, they have been classified in at least 13 different families according to their
sequence homology [1]. Protease inhibitors are denoted Kunitz-type inhibitor when
particular conserved amino acids are present in their primary structures, such as four
cysteinyl residues forming two disulphide bridges [1]. The Kunitz-type inhibitors are
relatively small (approximately 20 kDa) and are mostly monomeric and single-headed,
containing one reactive site that inhibits the protease. Kunitz-type inhibitors are pseudo-
substrates that bind directly to the binding site of the protease. To date, only monomeric
single-headed (e.g. winged bean chymotrypsin inhibitor) or monomeric double-headed
inhibitors (e.g. soybean trypsin inhibitor) have been crystallised. PSPI is a dimeric double-
headed Kunitz-type inhibitor with two subunits that differ in size (15 kDa for the larger
subunit and 6 kDa for the smaller one [2]). The subunits share about 22 % sequence
homology with the soybean trypsin inhibitor, the reference inhibitor for the Kunitz-type
[3]. Here, we describe the crystallisation conditions of a dimeric Kunitz-type inhibitor,
which inhibits trypsin, chymotrypsin and human leukocyte elastase [4].
Material and Methods
Purification
Potatoes of cv. Elkana (Avebe B.A., Veendam, The Netherlands) were stored at
277 K in the dark at a relative humidity of 95-100 % for a maximum period of six months.
The potatoes were chopped into large pieces and mixed in the presence of sodium
bisulphite (0.5 g/kg potatoes) to prevent oxidation of phenolic compounds. Potato juice
was prepared as described previously [4]. PSPI 6.1 (the number representing the
isoelectric point), one of the isoforms of PSPI group, was purified as described previously
[4]. PSPI 6.1 is a dimeric protein of 20 273 Da [2], in which the 2 sub-units are disulphide
linked; it shows approximately 22 % sequence homology with the Kunitz soybean trypsin
inhibitor. An additional chromatofocusing step was included, using a Poly-buffer
Exchanger 74 column (60 x 1.6 cm). The fraction containing PSPI 6.1 was loaded onto the
column, which had been pre-equilibrated with 0.025 M imidazole-HCl buffer (pH 7.4)
and the protein was eluted using a Polybuffer 74-HCl (pH 5.0) (dilution factor 1:8)
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(Amersham Biosciences, Uppsala, Sweden). The polybuffer was removed using a HP
phenyl sepharose column (10 x 2.6 cm). The chromatofocusing step resulted in the
removal of minor contaminants. After purification, PSPI 6.1 was dialysed at 277 K against
10 mM Tris-HCl buffer (pH 8.0) and subsequently stored (253 K) at a concentration of 1
mg ml-1.
Crystallisation
The purified PSPI 6.1 was concentrated to 10 mg ml-1 in 10 mM Tris-HCl buffer
(pH 8.0), using a centripep 10 kDa ultracentrifugation device (Millipore, Bedford, MA,
USA).
Crystallisation experiments were performed by the sitting-drop vapour-diffusion
method at 295 K. Each drop was formed by mixing equal volumes (1 µl) of 10 mg ml-1
PSPI 6.1 solution and reservoir solution. Crystals were grown (Figure 4.1) in 0.1 M
HEPES pH 7.5, 10 % PEG8000 and 8 % ethyleneglycol complemented with 9 mM 1-s-
octyl-β-D-thioglucoside (Hampton Detergent screen 1) or 0.1 M glycine (Hampton
Additive screen 2).
X-ray data collection and processing
A single crystal was soaked in reservoir solution containing 25 % glycerol for 10 s
and mounted on a nylon-fibre loop (Hampton), after which it was flash frozen in a liquid
nitrogen stream at 100 K. The data were collected at beamline ID29 of the European
Synchrotron Radiation Facility (ESRF) on an ADSC Q4R detector. The crystal-to-
Figure 4.1. Crystals of Potato Serine Protease Inhibitor (PSPI 6.1) in 0.1 M HEPES pH 7.5,
10 % PEG8000 and 8 % ethyleneglycol with detergent or additive. a) 9 mM 1-s-octyl-β-D-
thioglucoside b) 0.1 M glycine
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detector distance was 200 mm and 100° of 1° oscillation images (3 passes of 0.5 s per
frame) were collected (λ = 0.9464 Å) (Figure 4.2). The intensities were indexed with
MOSFLM [5] and scaled using SCALA [6]. Molecular replacement was performed using
AMORE [7], MOLREP [8] and BEAST [9], which are all available in the CCP4 program
suite [10].
Results
PSPI 6.1 was purified and crystallised as shown in Figure 4.1 a data set of a single
crystal was collected to 1.8 Å; because of the use of a square detector the completeness in
the highest resolution shell (1.90-1.80 Å) is only 52.1 %. In Figure 4.2 an X-ray
diffraction pattern of a PSPI 6.1 crystal is shown. The data was processed in space-group
P21, with unit cell parameters of a = 54.82, b = 93.92, c = 55.44 Å and β  = 100.7°. See
Table 4.1 for data-collection and processing parameters. The exact Matthews coefficient
(VM) and solvent content of the crystals could not be determined. Neither a self-rotation
function nor a native patterson indicated clear rotational or translational symmetry
between molecules in the asymmetric unit (A.U.). If there are 2 molecules in the A.U., VM
= 3.5 Å3 Da-1, corresponding to a solvent content of 64.2 %, whilst 3 molecules in the
A.U. gives a VM = 2.3 Å3 Da-1 and a solvent content of 46.2 %. According to the
Figure 4.2. X-ray diffraction pattern of a Potato Serine Protease Inhibitor (PSPI 6.1) crystal.
The resolution circles are given in Å.
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Matthews coefficient probabilities [11] the latter seems the more likely. We were not able
to solve the structure by molecular replacement using the winged bean chymotrypsin
inhibitor [12], which has a 32 % sequence homology or the Kunitz-type soybean trypsin
inhibitor as a model. Structure solution by heavy atom methods is in progress.
Table 4.1. Data-collection and processing parameters. Data statistics of the outer resolution shell
(1.90-1.80 Å) are given in parentheses, where applicable.
Native crystal  PSPI 6.1
Crystal dimensions (mm) 0.4 x 0.025 x 0.025
Temperature (K) 100
Wavelength (Å) 0.94644
Resolution range (Å) 54.23 - 1.80
Crystal system Monoclinic
Space-group P21
Unit cell parameters (Å) a = 54.82, b = 93.92, c = 55.44 and β  = 100.7°
Total No. reflections 89852
No. unique reflections 45456
Rsyma 0.044 (0.13)
Completeness (%) 88.7 (52.1)b
Average I/σ(I) 4.4 (5.6)
a Rsym = Σh Σi |Ihi - <Ih>| / Σh Σi |Ihi| , where Ihi is the intensity of the ith measurement of the same
reflection and <Ih> is the mean observed intensity for that reflection
b data in the higher-resolution shell are less complete because of data collection on a square detector
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Summary
Human lactoferrin (hLF) is an iron-binding glycoprotein involved in the host defence
against infection and excessive inflammation. As the availability of (human milk-derived)
natural hLF is limited, alternative means of production of this biopharmaceutical are
extensively researched. Here we report the crystal structure of recombinant hLF (rhLF) at
a resolution of 2.4 Å as it is expressed in the milk of transgenic cows. To our knowledge,
this is the first reported structure of a recombinant protein produced in milk of transgenic
livestock. Even though rhLF contains oligomannose- and hybrid-type N-linked glycans
next to complex-type glycans, which are the only glycans found on natural hLF, the
structures are identical within the experimental error (r.m.s. deviation of only 0.28 Å for
the main-chain atoms). Of the differences in polymorphic amino acids between the natural
and recombinant hLF variant used, only the side-chain of Asp561 could be modelled into
the rhLF electron density map. Taken together, the results confirm the structural integrity
of the rhLF variant used in this study. It also confirms the validity of the transgenic cow
mammary gland as a vehicle to produce recombinant human proteins.
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Introduction
Lactoferrin (LF) is a metal-binding glycoprotein of 77 kDa belonging to the
transferrin family [1]. The molecule is found in milk, tears, saliva, bronchial, intestinal
and other secretions, but also in the secondary granules of neutrophils [2]. Based on the
many reports of its antimicrobial and anti-inflammatory activity in vitro, LF is thought to
be involved in the host defence against infection and excessive inflammation, most
notably at mucosal surfaces [2]. Antimicrobial activities of LF include bacteriostasis by
the sequestration of free iron [3] and bactericidal activity by destabilisation of the cell-
wall [4,5]. Anti-inflammatory actions of LF include inhibition of hydroxyl-radical
formation [6], of complement activation [7] and of cytokine production [8] as well as
neutralisation of lipopolysaccharide (LPS) [9]. Because of these biological activities, a
wide variety of applications of LF in human health care has been proposed, such as the
treatment of infectious and inflammatory diseases. As a nutraceutical application, the
molecule may be used as a component of clinical nutrition products aimed at the
prevention and treatment of gastro-intestinal tract infections and inflammations.
The DNA and amino acid sequences of human lactoferrin (hLF) have been
determined [10,11]. Human LF consists of a polypeptide chain of 692 amino acids, which
is folded into two globular lobes [1]. These lobes, designated the N- and C-lobe, share an
internal amino acid homology of about 40% [11], they are connected by a three-turn α-
helix. Each lobe folds into α-helix and β-sheet arrays to form domains I and II,
respectively, which are connected by a hinge region, creating a deep iron-binding cleft
within each lobe. Each cleft binds a single ferric ion with high affinity while
simultaneously incorporating a bicarbonate ion [1]. Crystallographic studies of hLF have
showed that upon binding of iron, domain I of the N- and C-lobe rotates relative to
domain II by ~54° and ~20°, respectively, resulting in a more globular closed, and stable
conformation of the entire molecule [12]. Next to the high affinity metal binding in the
iron-binding cleft, LF also binds other metals albeit with much lower affinity [13]. This
occurs at least in part via surface-exposed histidyl residues [14]. Whereas some of the
biological activities of hLF relate to high or low affinity iron-binding, others are mediated
by a positively charged domain located in the N-terminus. This domain binds to
negatively charged ligands such as the lipid A portion of LPS [15], DNA [16], heparin
[17] as well as other proteins such as lysozyme [18] and specific receptors [19,20].
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Human LF contains three possible N-glycosylation sites, Asn138 in the N-lobe and
Asn479 as well as Asn624 in the C-lobe [10], which are utilised in about 94%, 100% and 9%
of the molecules, respectively [21].
Recently, we reported the production of recombinant hLF (rhLF) in the milk of
transgenic cows [22]. Comparative studies between rhLF and hLF from human milk
(natural hLF) revealed identical iron-binding and release properties, and despite
differences in N-linked glycosylation, equal effectiveness in various infection models
[22]. Here, we report the crystallographic structure of rhLF in its iron-saturated
conformation. The structure appeared to be identical to the structure reported for iron-
saturated natural hLF [23].
Material and Methods
Expression and purification of rhLF
The production and purification of rhLF from the milk of transgenic cows has been
described previously [22]. Briefly, a genomic hLF sequence with polymorphic amino
acids at position 4 (insertion of Arg), 11 (Ala), 29 (Arg) and 561 (Asp) [24] under control
of regulatory elements from the bovine αS1 casein gene, was introduced into the bovine
germline. The resulting transgenic cattle lines showed rhLF expression levels between 0.4
and 2.5 g/L. Purified rhLF was saturated with iron as described [18].
Crystallisation
Crystals were grown by micro-dialysis of rhLF (54 mg ml-1 in 0.9 % NaCl) in a
100 µl dialysis button against 5 mM sodium phosphate pH 8.5 with 10 % (v/v) ethanol at
4  °C. Deep red crystals appeared after 4 weeks and grew to dimensions of approximately
3 x 2 x 1 mm. The protein crystallised in the orthorhombic space-group P212121, with cell
dimensions a = 55.94, b = 97.38, and c = 156.30 Å with 1 molecule in the asymmetric
unit.
Data collection
The dialysis button was transferred to 5 mM sodium phosphate pH 8.5
complemented with 20% (v/v) 2-methyl-2,4-pentanediol (MPD) for a week at 4 °C to
stabilise the crystals, as described [1]. Part of a crystal was broken off and mounted in a
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quartz capillary. X-ray data were collected at room temperature on a FR591 rotating-
anode generator equipped with a MAR345 image-plate detector, using Cu Kα radiation (λ
= 1.5418 Å). The crystal-to-detector distance was 220 mm and a 0.5° oscillation angle
was used per image for a total of 369 images. The intensities were indexed with
MOSFLM [25] and scaled using SCALA [26]. During the scaling process it was observed
that a number of the images were not useful, which is most likely caused by a non-
uniform quality of the crystal in different directions. These images were left out of the
scaling process and not used any further. The resulting data set contained 154 images
(77°) and 104905 reflections of which 33492 were unique. The overall completeness of
the data set was 96.2 %, with a completeness of 97.9 % in the highest resolution bin (2.53
- 2.40 Å). The overall redundancy and Rsym were 3.3 and 0.057, respectively. Data
collection and processing details are summarised in Table 5.1.
Table 5.1. Data-collection and processing parameters
 Data collection rhLF expressed in bovine milk
Crystal dimensions (mm) 3 x 2 x 1
Wavelength (Å) 1.5418
Resolution range (Å) 81.65 - 2.40
Crystal system Orthorhombic
Space group P212121
Unit cell parameters (Å) a = 55.94, b = 97.38, c = 156.30
Total No. reflections 104905
No. unique reflections 33492
multiplicity 3.3 (3.3)a
Rsymb 0.057 (0.33)
Completeness (%) 96.2 (97.9)
Average I/σ(I) 8.9 (2.2)
solvent content (%) 55.51
VM (Å3 / Da) 2.8
a Data statistics of the outer resolution shell (2.53 - 2.40 Å) are given in parentheses, where
applicable. b Rsym = Σh Σi |Ihi - <Ih>| / Σh Σi |Ihi| , where Ihi is the intensity of the ith measurement of
the same reflection and <Ih> is the mean observed intensity for that reflection
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Structure elucidation and refinement
The structure was determined by molecular replacement, using MOLREP [27] and
the structure of iron-saturated natural hLF [23] as the search model. The search model
included two Fe3+ and two CO32- ions, but all waters and carbohydrates were omitted in
the model. The rotation and translation functions were determined, the best solution had
an R factor of 0.294 and a correlation coefficient of 0.814. Instead of a full molecular
replacement, a rigid body refinement could have been performed, after applying an anti-
clockwise rotation parallel to the b-axis on the search model, changing a into c and c into -
a, which would have given the same result. The model was refined using restrained
refinement using REFMAC [28] using 30833 reflections in the resolution range 19.63-
2.40 Å (for the refinement statistics see Table 5.2). Water molecules were built using ARP
[29]. Electron density maps were calculated and carbohydrates were fitted into the 2Fo - Fc
electron density. The final model was checked using PROCHECK [30] and WHATIF
[31].
Table 5.2. Refinement statistics
Refinement rhLF expressed in bovine milk
Resolution range (Å) 19.63 - 2.40
number of reflections 30833 (1640)a
Rfactorb 0.18 (0.23)
protein atoms / water molecules 5365 / 54
r.m.s. deviations bonds (Å) 0.013
r.m.s. deviations angles (°) 1.40
Average B value protein / solvent (Å2) 50.24 / 39.60
Average B value sugar / Fe3+/ CO32- (Å2) 86.29 / 31.90 / 26.43
Ramachandran statisticsc (%) 86.4 / 13.0 / 0.3 / 0.3
aData statistics of Rfree are given in parentheses, where applicable
bR = ||Fobs (hkl)| - |Fcalc(hkl)|| /  |Fobs(hkl)|
cAccording to the program PROCHECK [30]. The percentages are indicated of residues in the most
favoured, additionally allowed, generously allowed and disallowed regions of the Ramachandran
plot, respectively
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Structural comparisons
The structure of rhLF isolated from transgenic bovine milk was compared to the
structure of iron-saturated natural hLF (PDB-code 1LFG, [23]), using LSQKAB from the
CCP4 program suite [32]. The amino acid residues 1-4 and 1-5 from natural hLF and
rhLF, respectively, were disordered and therefore left out of the calculations.
Results and discussion
rhLF model
The final model for iron-saturated rhLF from transgenic bovine milk consists of
692 amino acid residues, 54 water molecules, two Fe3+ ions, two CO32- ions, and two N-
acetylglucosamine residues that are N-linked to Asn138 and Asn479 (numbering according
to [10]). The model has an R-factor of 0.18 and an Rfree of 0.23. The Ramachandran
statistics (Table 5.2) show 86.4 % of the residues to be in the "most favoured" regions and
13.3 % in the "allowed" regions; only 0.3 % is in the "disallowed" region, which are
residues Leu300 and Leu643. As was described before [23], both residues are located in a γ-
turn, which seems to be a conserved property of all transferrin structures determined. The
N-terminal amino acid stretch (Gly1-Arg2-Arg3-Arg4-Arg5-) was disordered and could not
be modelled, which is consistent with the experiences of other authors [23,33]. The
flexible surface loop at residues 418-424 showed no ordered density at 1σ, but at 0.7σ the
main-chain and most of the side-chain atoms became visible. Many of the amino acid
residues that are exposed to solvent have disordered side-chains, especially the long side-
chains of arginine and lysine residues, showing high B factors.
Protein structure
The structure of rhLF isolated from the milk of transgenic cows was determined in
its closed conformation. The folding of rhLF is the same as that of natural hLF isolated
from human milk (PDB code 1LFG). The structure of rhLF was superimposed on natural
hLF, the r.m.s. deviation in the atomic positions of the main-chain atoms is 0.28 Å,
diregarding the disordered N-terminus. The superimposed structures are shown in Figure
5.1, only the flexible loop of amino acid residues 418-424 and the N-terminus show
differences between the Cα atoms of the differently expressed hLF proteins, indicating
these residues may adopt alternative conformations.
121
Previously, we reported polymorphic sites in the hLF coding sequence at amino
acid position 4 (deletion of Arg), position 11 (Ala or Thr), position 29 (Arg or Lys) and
position 561 (Asp or Glu) [24]. Recombinant hLF differs from the natural hLF variant
described by Haridas et al. [23] at position 4 (- → Arg), 29 (Lys → Arg) and 561 (Glu →
Asp). The Arg4 residue of rhLF could not be modelled, the N-terminal stretch Gly1-Arg2-
Arg3-Arg4-Arg5 may however be modelled upon binding of heparin, as Arg2-Arg3-Arg4-
Arg5 is part of the positively charged domain responsible for binding of the ligand [17].
The side chain of the solvent-exposed Arg29 residue was disordered and could not be
modelled. Figure 5.2a shows the polymorphic site Asp561 in the 2Fo - Fc density map. The
polymorphic sites did neither change the structure of rhLF nor its biochemical activity,
compared to natural hLF [22].
Glycosylation
Human lactoferrin contains three possible N-glycosylation sites, Asn138 in the N-
lobe and Asn479 as well as Asn624 in the C-lobe [10], which are utilised in about 94%,
100% and 9% of the molecules, respectively [21]. The glycans of natural hLF are of the
Figure 5.1. Cα superposition of rhLF and natural hLF. rhLF expressed in bovine milk is shown
in yellow and natural hLF isolated from human milk in blue. Grey spheres show the iron atoms.
The figure was prepared with PyMOL [34]. For colour picture see Appendix A.
122
sialyl-N-acetyllactosaminic type [35].  Previously, we reported that rhLF from transgenic
bovine milk also contains oligomannose and/or hybrid-type glycans [22].
In the rhLF structure described here, interpretable density for single carbohydrates
was present at glycosylation sites Asn138 and Asn479. The two N-acetylglucosamine
residues were built into the 2Fo - Fc density map contoured at 0.9σ. The N-
acetylglucosamine at position Asn479 is shown in Figure 5.2b. Further carbohydrates were
insufficiently ordered to extend the model.
Conclusions
The application of rhLF from bovine milk in human health care requires a
thorough comparison of the physico-chemical and biological characteristics of the
recombinant with the natural form. Here we report that despite the presence of
polymorphic sites and differences in N-linked glycosylation, the three-dimensional
structure of recombinant hLF closely matches the structure of natural hLF. This
Figure 5.2. a) Crystallographic electron density surrounding Asp561. rhLF amino acid residues
Asn560, Asp561, Ala562, and Trp563 are shown in ball-and-stick representation with main chain
carbon atoms in light grey, surrounded by the final 2Fo - Fc electron density map contoured at
1σ. At the polymorphic position 561(numbering according to rhLF) the glutamatic acid (E) is
shown with main chain carbon atoms in dark grey. b) Crystallographic electron density
surrounding Asn479.  Amino acid residues Phe478, Asn479, and Gln480 and N-acetylglucosamine
(NAG) are shown in ball-and-stick representation surrounded by the final 2Fo - Fc electron
density map contoured at 0.9σ. Picture was prepared with BOBSCRIPT [36], which is based on
MOLSCRIPT [37].
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observation confirms earlier findings of identical biochemical activity of hLF from both
sources, paving the way for safe usage of rhLF in humans. In addition, the results
illustrate the potential of transgenic cows to produce recombinant human proteins with a
virtually identical structure compared to their human counterparts.
Coordinates. Coordinates and structure factors have been deposited in the Protein Data
Bank (accession code 2BJJ).
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Summary and Conclusions
The three-dimensional structure of proteins is important for understanding the
molecular basis for their specific activity. Several methods exist for investigating the
three-dimensional structure, each with its own advantages and disadvantages; nuclear
magnetic resonance (NMR) which has a restriction in the size of the protein, cryo-electron
microscopy (cryo-EM) which produces structures of limited resolution, and X-ray
crystallography. The main problem to overcome in X-ray crystallography is the
requirement of three-dimensional, well diffracting crystals. The determination of the
crystallisation conditions is still a daunting task for most proteins and essentially a trial
and error procedure. As this is a very time- and protein-consuming task, many groups are
developing or using robots to perform crystallisation trials in the nano-litre volume range.
After obtaining crystals, the resolution that can be achieved in X-ray crystallography
depends on the quality of the crystals. Through the application of synchrotron beam-lines,
however, a resolution of 1.5 Å or even better is not an unrealistic goal anymore.
This thesis describes the purification of several different proteins as well as
crystallisation experiments, in order to determine their structure. Unfortunately, problems
in obtaining correctly folded protein and diffracting crystals in two cases prevented the
elucidation of the full 3D atomic structure. Therefore other methods had to be used to get
a glimpse of the structural basis of some of these proteins.
The human T cell receptor-CD3 complex consists of at least eight polypeptide
chains: CD3γε- and δε-dimers associate with the disulphide linked αβ- and ζζ-dimers to
form a functional receptor complex. The exact interactions within this complex are still
unknown, therefore the impact of single amino acid mutations in the CD3γ chain on the
CD3γε heterodimer interaction was investigated. Four amino acid residues were mutated
in the CD3γ chain to different conserved or non-conserved residues and introduced in
human T cells defective in CD3γ-expression. Intracellular as well as cell surface
expression of the introduced CD3γ chains was determined as well as the association with
CD3δ, CD3ε and the T cell receptor. Because cells from a CD3γ deficient patient were
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available, a comparison to this negative control could be made. The results of these
experiments are described in chapter 2.1, showing the three phenotypes that were
observed: i) the introduction of wild type CD3γ and CD3γ(78Y-F) fully restored the T cell
receptor assembly and expression; ii) the introduction of CD3γ(82C-S), CD3γ(85C-S),
and CD3γ(76Q-E) all resulted in an impaired association between CD3γ and CD3ε and a
lack of cell surface expressed CD3γ; iii) the introduction of CD3γ(76Q-L) and CD3γ(78Y-
A) restored the expression of TCR-δεγεζ2 complexes although the association between
CD3γ and CD3ε was impaired. These results show that particular amino acids in the CD3γ
chain are very important for optimal association between CD3γ and CD3ε and the
assembly of a cell surface expressed αβTCR-δεγεζ2 complex.
In order to determine the structure of the intracellular domains of the human CD3δ
and CD3ε that are thought to be important for the intracellular dimer formation, synthetic
peptides corresponding to these domains have been synthesised. CD3δ is a 44-mer,
molecular weight and calculated pI of 4995.38 Da and 6.93, respectively. CD3ε is a 55-
mer, with molecular weight and pI of 6179.03 Da and 11.52, respectively. Many different
crystallisation trials were performed, but for CD3ε this did not result in even the
formation of micro-crystals. The crystallisation trials for CD3δ resulted in "sea urchin"
type crystals of poor quality. Several rounds of micro-seeding the needles of the "sea
urchin" did not result in better crystals. NMR spectra of the peptides showed poor
dispersion and narrow line width, therefore it was concluded that the peptides are
primarily random coil. After mixing of the peptides a 1D proton NMR was recorded, the
spectrum of the combined peptides was a superimposition of the 2 spectra of the single
peptides, leading to the conclusion that no interaction or folding is indicated by this NMR
experiment. These experiments are described in chapter 2.2.
The bacteriophage T4, a bacterial virus which infects Escherichia coli, looks like a
sort of moon-lander. It has a DNA containing head with a contractile tail and short and
long tail fibres attached to a so-called baseplate. It adsorbs to the host’s cell receptor via
its long tail fibres and next the short tail fibres fold out from under the baseplate and also
bind to the host’s cell receptor. With a needle-like puncturing device, a hole is drilled into
the host cell, providing the entry for DNA injection. After the phage particles are formed
in the host cell, the host will burst and the new phages are released.
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In chapter 3.1, the structure of the receptor-binding domain of the short tail fibre is
described based on a 1.5 Å resolution X-ray structure determination. The short tail fibres
are formed by trimers of the gene product 12 (gp12) and are attached to the baseplate via
gp11. They contain 527 amino acids and are very stable, the protein needs to be heated to
56 °C before partial unfolding occurs. It was known that the full-length gp12 could not be
crystallised due to aggregation. To overcome this problem, the protein was mildly
proteolysed after partially unfolding in the hope of getting a shorter fragment of gp12 that
would be able to crystallise. In the presence of zinc during the proteolysis, a 45 kDa
fragment of gp12 was obtained, containing amino acids 85-527 according to N-terminal
sequencing. The electron density map, however, only showed good electron-density for
residues 330-527. The residues 85-329 seemed to be disordered in the crystal. Bacterial
cell binding experiments showed that the 45 kDa fragment contains the receptor-binding
domain, which was lacking in an earlier elucidated structure. The structure of the
receptor-binding domain reveals a knitted trimeric metal-binding fold, containing one zinc
ion octahedrally coordinated by the Nε2 of six histidine residues. It was reported earlier
that gp12 was a zinc metallo-protein, assumed to contain one zinc atom per monomer. In
the structure described in chapter 3.1, one zinc atom per trimer was found (although it was
not possible to rule out that their are other zinc binding sites in the parts missing in the
structure). The structure looked as if the protein was knotted, but after having a closer
look the protein turned out to be knitted, i.e. it does not produce a topological knot upon
"pulling at the ends". The three strands, with hardly any regular secondary structure
elements, are intensively intertwined and together with the octahedrally coordinated zinc
ion this gives the trimeric protein a very stable conformation. No related structure in the
protein structure database could be found. The collar domain has some limited structural
homology with the central domain of gp11, which is the connector protein between the
baseplate and the short tail fibre (gp12).
Some suggestions have been made for binding of the LPS to the receptor-binding
domain, based on the nature of the LPS core. It was assumed that phosphate groups bind
to positive charges on the protein surface while the sugars bind to the aromatic side-
chains. The trimer in general, and its top in particular, is positively charged, which could
contribute to its affinity for the negatively charged E.coli membrane. Along the sides of
the trimer there are three groves which are flanked by or contain positively charged
residues and aromatic amino acids. Each of these grooves may bind an LPS molecule.
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This means that there is very tight binding between T4 and the host cell, if it is considered
that the bacteriophage T4 has six short tail fibres which can bind simultaneously to the
E.coli membrane, each through three receptor-binding sides.
In order to determine were the receptor-binding domain is capable of binding to the
host cell’s lipopolysaccharides (LPS), crystallisation experiments were performed with the
45 kDa fragment in the presence of LPS. The results described in chapter 3.2 show that
the fragment did not crystallise with LPS bound to it, but surprisingly the crystals had a
different space-group and showed more ordered density. Electron density was now present
for amino acid residues 246-527. The overall structures of the visible parts for the two
gp12 trimers in space group R32 and P321 are the same. After superposition of the two
trimers, amino acid residues 465-479 in the "bonnet" (the top of the trimeric protein
containing the receptor-binding domain) show differences in the main-chain positions.
Whether these changes are caused by differences in crystal contacts or by the LPS present
in the crystallisation trials is unknown. Low-resolution density was present for some of
the residues between 85-245. Attemps to improve the map by density modification using a
solvent mask were unsuccessful. Also searching for repeats in the N-terminal electron
density knowing that the N-terminal domain contains six repeats of which one is visible in
the 45 kDa structure, did not result in better maps and Rfactors. Regrettably, it was not
possible to interpret the low-resolution density.
In collaboration with the university of Wageningen a potato serine protease
inhibitor (PSPI) was crystallised. Serine protease inhibitors are important due to their
potent activity in preventing carcinogenesis in a wide variety of in vivo and in vitro model
systems. Potato tubers contain a wide range of such protease inhibitors. In cv. Elkana
potato tubers, protease inhibitors represent about 50 % of the total amount of soluble
protein. One of the isoforms of the most abundant protease inhibitor, a dimeric double-
headed Kunitz-type inhibitor, was crystallised. No high-resolution structural information
on this type of inhibitors had so far been obtained, as all structures known at that time
were of the monomeric single-headed or monomeric double-headed types. Crystals were
grown and a native data set was collected to 1.8 Å resolution. Due to the lack of a dimeric
double-headed inhibitor model in the PDB, so far the structure could not be solved by
molecular replacement. Using monomeric double-headed and dimeric single-headed
models did not result in the elucidation of the structure. Unfortunately these models were
not homologous enough and therefore did not result in a solution. Heavy atom derivative
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trials were performed, but resulted in the disruption of the crystal lattice or to low
occupancies for the heavy metal positions. The crystallisation conditions are described in
chapter 4. As soon as a suitable model for molecular replacement becomes available, the
structure will be determined.
Human lactoferrin (hLF) is an iron-binding glycoprotein involved in the host
defence against infection and excessive inflammation. Together with Pharming in Leiden
the crystal structure of recombinant human lactoferrin (rhLF) expressed in the milk of
transgenic cows was reported at a resolution of 2.4 Å. As far as is known the first
structure of a recombinant protein produced in milk of transgenic livestock. The results
described in chapter 5 show that the structures of rhLF and natural hLF (derived from
human milk) are identical despite differences in N-linked glycosylation, confirming the
validity of the transgenic cow mammary gland as a vehicle to produce recombinant
human proteins.

135
Nederlandse samenvatting
De kristalstructuurbepaling van eiwitten door middel van Röntgen-diffractie is
één manier waarmee de driedimensionale structuur van een eiwit bepaald kan worden.
Aan de hand van de verkregen informatie kan vaak iets gezegd worden over de functie en
de werking van het eiwit. Röntgen-diffractie wordt ook gebruikt in de ontwikkeling van
medicijnen. Om te beginnen wordt de structuur van het ziekteverwekkende eiwit, het
zogenaamde “target eiwit”, bepaald. De kennis van deze structuur wordt vervolgens
gebruikt om geschikte medicijnen te ontwikkelen. Deze medicijnen moeten in staat zijn
het aktief gedeelte van het “target eiwit” te binden, om daardoor de activiteit van het eiwit
uit te schakelen. Aan de hand van de kristalstructuur van “target eiwit” met het daaraan
gebonden medicijn kan gekeken worden of het mogelijk is de eigenschappen van het
medicijn te verbeteren. Dit kan door bijvoorbeeld het medicijn zo te veranderen dat de
binding van het medicijn aan het “target eiwit” versterkt wordt waardoor een lagere
dosering van het desbetreffende medicijn mogelijk is. De eiwitkristallografie is in de
laatste jaren enorm verbeterd, door o.a. sterkere Röntgenbronnen, waardoor een resolutie
van 1.5 Å of hoger niet langer een onrealistisch doel is. In de eiwitkristallografie wordt
gewerkt met de eenheid Angstrom (Å), 1 Å = 1.0 x 10-10 m, en komt ongeveer overeen
met de afstand tussen twee atomen in de materie.
Dit proefschrift beschrijft de zuivering en kristallisatie van verschillende
eiwitten. In hoofdstuk 1 worden twee van de bestudeerde eiwitten besproken. Een van
deze eiwitten betreft het menselijk T cel receptor CD3 complex (TCR-CD3), dat
tenminste uit acht eiwitketens bestaat, namelijk de αβ-keten, het δε- en εγ-dimeer en het
ζζ-dimeer. Er zijn nog steeds discussies gaande of dit werkelijk de samenstelling is van
het TCR-CD3 complex. In hoofdstuk 1 wordt verder een introductie gegeven over de
bacteriofaag T4, een virus dat in staat is bacteriën te infecteren. Het virus heeft de
uiterlijke kenmerken van een maanlander. Het virus heeft 6 lange en 6 korte pootjes die
aan de gastheercel binden voor en tijdens de infectie. Deze pootjes zorgen ervoor dat
tijdens de infectie de bacteriofaag zijn DNA via een zogenaamde injectiespuit kan
injecteren in de gastheercel. Er was nog weinig structurele informatie beschikbaar over
deze pootjes. Na infectie vermenigvuldigt de bacteriofaag zich in de gastheer totdat deze
openscheurt en de nieuwe bacteriofagen vrij komen.
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De overproductie en zuivering van verschillende CD3 ketens leverde geen
gevouwen eiwitten op, wat de poging tot kristallisatie deed mislukken. In diezelfde
periode werd de NMR structuur beschreven van het CD3εγ heterodimeer, dit deed mij
besluiten de hoofdlijn in het onderzoek te verschuiven. In plaats van op de kristallisatie
werd het onderzoek gericht op de associatie tussen de verschillende heterodimeren in vivo.
In hoofdstuk 2 is de invloed beschreven van mutaties in de CD3γ keten op de associatie
in vivo van het CD3εγ dimeer en de daaropvolgende T cel receptor CD3 complexvorming.
De resultaten laten zien dat bepaalde aminozuren in de CD3γ keten erg belangrijk zijn
voor een goede associatie van het CD3εγ heterodimeer. Sommige mutaties verhinderen
een goede vorming van het αβδεεγζζ complex op het celmembraan, ondanks het feit dat
FACS analyse aantoonde dat de cellen CD3 positief zijn. Mogelijkerwijs is in deze cellen
de samenstelling van het TCR-CD3 complex op het cel-oppervlak veranderd in
αβδεδεγζζ. Aangezien de CD3δ keten grote overeenkomsten vertoont met de CD3γ keten
zou dit een mogelijkheid kunnen zijn. Tevens werden gesynthetiseerde peptiden van de
intracellulaire domeinen van CD3δ en CD3ε gebruikt voor kristallisatie en NMR
experimenten. Uit deze experimenten blijkt dat de beide peptiden onder de heersende
omstandigheden zich niet in een gevouwen conformatie bevinden en daardoor
structuurbepaling uitgesloten is.
In hoofdstuk 3 is de kristalstructuur van het receptorbindende domein van de
korte pootjes van de bacteriofaag T4 beschreven. De structuur bestaat uit drie identieke
ketens die als in een knotje in elkaar geweven zijn. In het midden van deze drie ketens is
een zink ion aanwezig. Alle drie de ketens binden aan dit ion door middel van twee
histidine aminozuren. Dit zink-ion blijkt voor een grote stabilisatie van het trimeer te
zorgen, want wanneer het verwijderd wordt door middel van EDTA blijkt het receptor
bindende domein bij verhitting uit elkaar te vallen. Terwijl bij aanwezigheid van zink het
receptorbindende domein bij verhitting niet ontvouwt. Tevens worden in hoofdstuk 3
resultaten beschreven betreffende hetzelfde eiwit maar dan gekristalliseerd in een andere
ruimtegroep. In deze kristalvorm blijkt een groter deel van de elektronendichtheid
geordend te zijn in vergelijking met de eerder verkregen kristallen. In deze extra
elektronendichtheid kon de structuur van een fragment van de korte pootjes (het 33 kDa
fragment) worden ingebouwd. Echter tot op heden was het niet mogelijk om overal in
deze extra elektronendichtheid aminozuren te bouwen.
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In samenwerking met de universiteit van Wageningen kristalliseerde ik een
serine protease inhibitor (PSPI, potato serine protease inhibitor) uit aardappel en kon ik
een natieve dataset tot 1.8 Å meten. Deze resultaten staan beschreven in hoofdstuk 4.
Deze protease inhibitors zijn onlangs in de belangstelling gekomen vanwege hun
mogelijke anti-kanker activiteit. De PSPI is het eerste “double-headed” dimeer waarvan
de kristallisatiecondities zijn beschreven. Andere protease inhibitors waarvan de
driedimensionale structuur bekend is, zijn of een “double-headed” monomeer dan wel een
“single-headed” dimeer. Helaas was geen van de aanwezige structuren in de PDB geschikt
als zoekmodel in de Molecular Replacement. De gemaakte derivaten vertoonden een te
lage bezetting van de zware atomen of verstoorden het kristalrooster, waardoor de
structuur nog niet bepaald kon worden.
 In hoofdstuk 5 worden de resultaten beschreven van de structuurbepaling van
menselijk lactoferrine (hLF) geproduceerd in melk van transgene koeien. Dit onderzoek
werd uitgevoerd in samenwerking met Pharming te Leiden. De resultaten laten zien dat
ondanks de verschillen in N-linked glycosylatie, de kristalstructuur van hLF uit transgene
koeienmelk overeenkomt met die van hLF geïsoleerd uit menselijke melk. Er was door
Pharming aangetoond dat er geen verschil is in beide lactoferrines, getest in diverse
biochemische experimenten en deze structuurbepaling bevestigt de mogelijkheid
transgene koeien te gebruiken voor de productie van menselijke recombinante eiwitten in
melk.
Hoofdstuk 6 is een samenvatting met de daarbijbehorende conclusies.
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List of abbreviations
APC: antigen-presenting cell
BCR: B cell receptor
BLAST: basic local alignment search tool
BSA: bovine serum albumin
CD: clusters of differentiation
cv: cultivar
dCTP: deoxycytidine 5'-triphosphate
DNA: deoxyribonucleic acid
DOC: sodium deoxycholate
E. coli: Escherichia coli
EDTA: ethylenediaminetetra-acetic acid
ER: endoplasmic reticulum
FACS: fluorescence activated cell sorter
FBS: fetal bovine serum
FCS: fetal calf serum
FITC: fluorescein isothiocyanate
GAM-FITC: goat anti-mouse - fluorescein isothiocyanate
GFP: green fluorescent protein
gp: gene product
h: hour
HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
hLF: human LF
Hm-dCTP: 5-hydroxymethyl dCTP
hoc: highly antigenic outer capsid
HSA: human serum albumin
Ig: immunoglobulin
IMDM: Iscove's modified Dulbecco's medium
IPTG: Isopropyl β-D-thiogalactoside
iron-saturated rhLF: rhLF that has completely been saturated with iron in vitro
ITAM: immunoreceptor tyrosine-based activation motif
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kDa: kilodalton
KDO: 2-keto-3-deoxyoctonic acid
LF: lactoferrin
LPS: lipo-polysaccharide
LTF: long tail fibre
mAb: monoclonal antibody
mCi: milli-currie
MHC: major histocompatiblity complex
min: minute(s)
natural hLF: hLF purified from human milk
NHS: normal human serum
nm: nano-meter
NMR: nuclear magnetic resonance
NP40: Nonident-40
NRS: normal rabbit serum
OmpC: outer membrane protein C
PAGE: poly-acrylamide gel electrophoresis
PAS: protein A sepharose
PBMC: Peripheral blood mononuclear cells
PBS: phosphate-buffered saline
PE: phycoerythrin
PEG: polyethylene glycol
PHA: phytohemagglutinin
pI: iso-electric point
PSPI: potato serine protease inhibitor
PTK: protein tyrosine kinases
rhLF: recombinant hLF
rIL: recombinant interleukin
SDS: sodium dodecylsulphate
soc: small outer capsid
STF: short tail fibre
TCR: T cell receptor
TM: transmembrane
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te maken. Aan het begin van dit project werd gestart in de groep Koning. Ook al waren
mijn voordrachten over een totaal ander onderwerp dan jullie gewend waren, jullie waren
altijd enthousiast en bereid iets nieuws te leren. Hier wil ik graag enkele mensen noemen.
Yvonne, je hebt me iets laten zien van de wereld die celkweek heet. Liesbeth, het was
plezierig met je samen te werken in het "CD3γ-mutanten" project, het duurde uiteindelijk
iets langer dan verwacht. Allan, het “namen-probleem” is waarschijnlijk verholpen sinds
ik in het Gorlaeus zit. Willemijn, ook al ben je enige tijd geleden al vertrokken uit L320,
ik ben erg blij dat je altijd bereikbaar bent voor een goed gesprek of een ontspannend
dagje in de sauna (het gaat ons misschien nog eens lukken).
Na een verhuizing richting het Gorlaeus nam ik mijn intrek in L005 bij de groep
biofysische structuurchemie. Hier was er altijd plaats voor een lach en een liedje naast de
wetenschap (Stil!! RAG). Collega's en oud-collega’s, jullie waren altijd in voor een
bezoekje aan de borrelbunker of een hapje en drankje in de stad waar de nodige discussies
plaatsvonden over het werk. De studenten Gerrit en Rinus, door jullie enthousiaste
medewerking tijdens jullie stage bij BFSC is hoofdstuk 3 tot stand gekomen. Jasper, door
jouw toedoen ben ik waarschijnlijk een van de weinige Limburgers die de liedjes van
Rubberen Robbie kan meezingen. Marike, na de nodige stress op het werk was het altijd
heerlijk om mijn agressie kwijt te kunnen door op zo'n klein balletje te slaan (sorry, voor
de momenten dat het balletje jou een mooie blauwe plek bezorgde). Alle vrienden,
volleyballers en “Nare-geidten”, jullie waren onmisbaar voor de nodige ontspanning en
inspanning gedurende mijn aio-periode. Hopelijk mag ik hier nog lang van genieten.
En niet in de laatste plaats mijn ouders, jullie stonden altijd voor me klaar ook al
had ik soms rare plannen tijdens mijn studie. Zoals jullie zien is er toch nog wat van mij
terechtgekomen zonder HAVO-diploma en MLO-stage. Ik ben heel blij met jullie onvoor-
waardelijke steun en vertrouwen. Ik hoop dat jullie na het lezen van dit proefschrift iets
meer begrijpen waar ik mee bezig ben geweest de laatste jaren.
Ellen

